2018-06-20 19:23:23,975:INFO: Disease Protein Prediction in the PPI Network
2018-06-20 19:23:23,976:INFO: Sabri Eyuboglu  -- SNAP Group
2018-06-20 19:23:23,976:INFO: ======================================
2018-06-20 19:23:23,976:INFO: Loading PPI Network...
2018-06-20 19:23:38,996:INFO: Loading Disease Associations...
2018-06-20 19:23:39,029:INFO: Loading PPI Matrix...
2018-06-20 19:24:14,188:INFO: Running Experiment...
2018-06-20 19:24:14,197:INFO: Experiment Progress: 0.0% -- 0/519
2018-06-20 19:24:14,847:INFO: Hydrops Fetalis, Non-Immune Recall-at-100: 40.00%
2018-06-20 19:24:14,848:INFO: Experiment Progress: 0.0% -- 1/519
2018-06-20 19:24:15,438:INFO: Psychoses, Substance-Induced Recall-at-100: 5.00%
2018-06-20 19:24:15,440:INFO: Experiment Progress: 0.0% -- 2/519
2018-06-20 19:24:16,003:INFO: Zellweger Syndrome Recall-at-100: 100.00%
2018-06-20 19:24:16,003:INFO: Experiment Progress: 0.0% -- 3/519
2018-06-20 19:24:17,119:INFO: Psoriasis Recall-at-100: 10.71%
2018-06-20 19:24:17,119:INFO: Experiment Progress: 0.0% -- 4/519
2018-06-20 19:24:17,732:INFO: Nephrotic Syndrome Recall-at-100: 8.33%
2018-06-20 19:24:17,732:INFO: Experiment Progress: 0.0% -- 5/519
2018-06-20 19:24:18,195:INFO: Nephrosis Recall-at-100: 30.00%
2018-06-20 19:24:18,196:INFO: Experiment Progress: 1.0% -- 6/519
2018-06-20 19:24:18,633:INFO: Mouth Diseases Recall-at-100: 25.00%
2018-06-20 19:24:18,633:INFO: Experiment Progress: 1.0% -- 7/519
2018-06-20 19:24:19,256:INFO: MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 86.67%
2018-06-20 19:24:19,256:INFO: Experiment Progress: 1.0% -- 8/519
2018-06-20 19:24:20,723:INFO: Substance-Related Disorders Recall-at-100: 3.91%
2018-06-20 19:24:20,724:INFO: Experiment Progress: 1.0% -- 9/519
2018-06-20 19:24:21,167:INFO: Anemia, Hemolytic Recall-at-100: 25.00%
2018-06-20 19:24:21,167:INFO: Experiment Progress: 1.0% -- 10/519
2018-06-20 19:24:24,611:INFO: Rheumatoid Arthritis Recall-at-100: 2.36%
2018-06-20 19:24:24,612:INFO: Experiment Progress: 2.0% -- 11/519
2018-06-20 19:24:25,187:INFO: Arthritis, Psoriatic Recall-at-100: 10.00%
2018-06-20 19:24:25,187:INFO: Experiment Progress: 2.0% -- 12/519
2018-06-20 19:24:25,961:INFO: Anemia Recall-at-100: 11.67%
2018-06-20 19:24:25,961:INFO: Experiment Progress: 2.0% -- 13/519
2018-06-20 19:24:26,810:INFO: Cholangiocarcinoma Recall-at-100: 20.00%
2018-06-20 19:24:26,811:INFO: Experiment Progress: 2.0% -- 14/519
2018-06-20 19:24:27,369:INFO: Neuroendocrine Tumors Recall-at-100: 30.00%
2018-06-20 19:24:27,369:INFO: Experiment Progress: 2.0% -- 15/519
2018-06-20 19:24:28,010:INFO: Malaria Recall-at-100: 10.00%
2018-06-20 19:24:28,010:INFO: Experiment Progress: 3.0% -- 16/519
2018-06-20 19:24:28,827:INFO: Hyperhomocysteinemia Recall-at-100: 15.00%
2018-06-20 19:24:28,827:INFO: Experiment Progress: 3.0% -- 17/519
2018-06-20 19:24:30,477:INFO: HIV Infections Recall-at-100: 19.00%
2018-06-20 19:24:30,477:INFO: Experiment Progress: 3.0% -- 18/519
2018-06-20 19:24:31,036:INFO: Ankylosing spondylitis Recall-at-100: 10.00%
2018-06-20 19:24:31,036:INFO: Experiment Progress: 3.0% -- 19/519
2018-06-20 19:24:32,632:INFO: Adenoid Cystic Carcinoma Recall-at-100: 9.11%
2018-06-20 19:24:32,632:INFO: Experiment Progress: 3.0% -- 20/519
2018-06-20 19:24:34,404:INFO: Juvenile arthritis Recall-at-100: 5.00%
2018-06-20 19:24:34,404:INFO: Experiment Progress: 4.0% -- 21/519
2018-06-20 19:24:35,145:INFO: Neoplasms, Experimental Recall-at-100: 17.50%
2018-06-20 19:24:35,145:INFO: Experiment Progress: 4.0% -- 22/519
2018-06-20 19:24:35,654:INFO: Neoplasms, Germ Cell and Embryonal Recall-at-100: 10.00%
2018-06-20 19:24:35,654:INFO: Experiment Progress: 4.0% -- 23/519
2018-06-20 19:24:36,111:INFO: Alopecia Areata Recall-at-100: 33.33%
2018-06-20 19:24:36,111:INFO: Experiment Progress: 4.0% -- 24/519
2018-06-20 19:24:36,662:INFO: Alopecia Recall-at-100: 5.00%
2018-06-20 19:24:36,663:INFO: Experiment Progress: 4.0% -- 25/519
2018-06-20 19:24:37,233:INFO: Bradycardia Recall-at-100: 50.00%
2018-06-20 19:24:37,233:INFO: Experiment Progress: 5.0% -- 26/519
2018-06-20 19:24:37,735:INFO: Common Variable Immunodeficiency Recall-at-100: 60.00%
2018-06-20 19:24:37,736:INFO: Experiment Progress: 5.0% -- 27/519
2018-06-20 19:24:38,433:INFO: Glomerulonephritis Recall-at-100: 31.67%
2018-06-20 19:24:38,433:INFO: Experiment Progress: 5.0% -- 28/519
2018-06-20 19:24:39,410:INFO: Alcoholic Intoxication, Chronic Recall-at-100: 11.67%
2018-06-20 19:24:39,410:INFO: Experiment Progress: 5.0% -- 29/519
2018-06-20 19:24:40,015:INFO: Lung Injury Recall-at-100: 20.00%
2018-06-20 19:24:40,016:INFO: Experiment Progress: 5.0% -- 30/519
2018-06-20 19:24:40,440:INFO: Hypercalcemia Recall-at-100: 50.00%
2018-06-20 19:24:40,440:INFO: Experiment Progress: 5.0% -- 31/519
2018-06-20 19:24:41,169:INFO: Cerebrovascular accident Recall-at-100: 20.00%
2018-06-20 19:24:41,169:INFO: Experiment Progress: 6.0% -- 32/519
2018-06-20 19:24:41,957:INFO: Diaphragmatic Hernia Recall-at-100: 15.00%
2018-06-20 19:24:41,957:INFO: Experiment Progress: 6.0% -- 33/519
2018-06-20 19:24:42,415:INFO: Prostatic Intraepithelial Neoplasias Recall-at-100: 30.00%
2018-06-20 19:24:42,415:INFO: Experiment Progress: 6.0% -- 34/519
2018-06-20 19:24:43,134:INFO: Migraine Disorders Recall-at-100: 20.00%
2018-06-20 19:24:43,134:INFO: Experiment Progress: 6.0% -- 35/519
2018-06-20 19:24:43,565:INFO: Restless Legs Syndrome Recall-at-100: 0.00%
2018-06-20 19:24:43,566:INFO: Experiment Progress: 6.0% -- 36/519
2018-06-20 19:24:44,090:INFO: Brugada Syndrome (disorder) Recall-at-100: 25.00%
2018-06-20 19:24:44,091:INFO: Experiment Progress: 7.0% -- 37/519
2018-06-20 19:24:44,579:INFO: Pathological accumulation of air in tissues Recall-at-100: 30.00%
2018-06-20 19:24:44,580:INFO: Experiment Progress: 7.0% -- 38/519
2018-06-20 19:24:45,014:INFO: Craniosynostosis Recall-at-100: 15.00%
2018-06-20 19:24:45,015:INFO: Experiment Progress: 7.0% -- 39/519
2018-06-20 19:24:45,593:INFO: Head and Neck Neoplasms Recall-at-100: 13.33%
2018-06-20 19:24:45,593:INFO: Experiment Progress: 7.0% -- 40/519
2018-06-20 19:24:46,191:INFO: Brain Neoplasms Recall-at-100: 18.33%
2018-06-20 19:24:46,191:INFO: Experiment Progress: 7.0% -- 41/519
2018-06-20 19:24:46,753:INFO: Hearing Loss, Partial Recall-at-100: 0.00%
2018-06-20 19:24:46,754:INFO: Experiment Progress: 8.0% -- 42/519
2018-06-20 19:24:47,251:INFO: Chromosome Aberrations Recall-at-100: 20.00%
2018-06-20 19:24:47,251:INFO: Experiment Progress: 8.0% -- 43/519
2018-06-20 19:24:48,208:INFO: Chronic Lymphocytic Leukemia Recall-at-100: 10.00%
2018-06-20 19:24:48,208:INFO: Experiment Progress: 8.0% -- 44/519
2018-06-20 19:24:49,000:INFO: Refractive Errors Recall-at-100: 0.00%
2018-06-20 19:24:49,000:INFO: Experiment Progress: 8.0% -- 45/519
2018-06-20 19:24:49,536:INFO: Hepatitis C Recall-at-100: 10.00%
2018-06-20 19:24:49,536:INFO: Experiment Progress: 8.0% -- 46/519
2018-06-20 19:24:50,360:INFO: Mesothelioma Recall-at-100: 5.00%
2018-06-20 19:24:50,361:INFO: Experiment Progress: 9.0% -- 47/519
2018-06-20 19:24:50,536:INFO: Noise-induced hearing loss Recall-at-100: 40.00%
2018-06-20 19:24:50,537:INFO: Experiment Progress: 9.0% -- 48/519
2018-06-20 19:24:51,270:INFO: Inflammatory dermatosis Recall-at-100: 0.00%
2018-06-20 19:24:51,271:INFO: Experiment Progress: 9.0% -- 49/519
2018-06-20 19:24:51,906:INFO: Kallmann Syndrome Recall-at-100: 20.00%
2018-06-20 19:24:51,906:INFO: Experiment Progress: 9.0% -- 50/519
2018-06-20 19:24:52,426:INFO: Lipoidosis Recall-at-100: 10.00%
2018-06-20 19:24:52,426:INFO: Experiment Progress: 9.0% -- 51/519
2018-06-20 19:24:53,049:INFO: Diabetes Mellitus Recall-at-100: 6.67%
2018-06-20 19:24:53,049:INFO: Experiment Progress: 10.0% -- 52/519
2018-06-20 19:24:53,818:INFO: Fibrosis Recall-at-100: 22.50%
2018-06-20 19:24:53,818:INFO: Experiment Progress: 10.0% -- 53/519
2018-06-20 19:24:54,343:INFO: Hypercholesterolemia Recall-at-100: 10.00%
2018-06-20 19:24:54,344:INFO: Experiment Progress: 10.0% -- 54/519
2018-06-20 19:24:54,918:INFO: Microcephaly Recall-at-100: 15.00%
2018-06-20 19:24:54,918:INFO: Experiment Progress: 10.0% -- 55/519
2018-06-20 19:24:55,285:INFO: Tongue Neoplasms Recall-at-100: 0.00%
2018-06-20 19:24:55,285:INFO: Experiment Progress: 10.0% -- 56/519
2018-06-20 19:24:55,733:INFO: Common Migraine Recall-at-100: 0.00%
2018-06-20 19:24:55,734:INFO: Experiment Progress: 10.0% -- 57/519
2018-06-20 19:24:56,188:INFO: Carotid Artery Diseases Recall-at-100: 0.00%
2018-06-20 19:24:56,188:INFO: Experiment Progress: 11.0% -- 58/519
2018-06-20 19:24:56,892:INFO: Growth Disorders Recall-at-100: 2.50%
2018-06-20 19:24:56,893:INFO: Experiment Progress: 11.0% -- 59/519
2018-06-20 19:24:57,345:INFO: Absence Epilepsy Recall-at-100: 0.00%
2018-06-20 19:24:57,347:INFO: Experiment Progress: 11.0% -- 60/519
2018-06-20 19:24:58,056:INFO: Epilepsy, Temporal Lobe Recall-at-100: 36.67%
2018-06-20 19:24:58,056:INFO: Experiment Progress: 11.0% -- 61/519
2018-06-20 19:24:59,159:INFO: Memory Disorders Recall-at-100: 5.00%
2018-06-20 19:24:59,160:INFO: Experiment Progress: 11.0% -- 62/519
2018-06-20 19:25:00,141:INFO: Catalepsy Recall-at-100: 45.00%
2018-06-20 19:25:00,141:INFO: Experiment Progress: 12.0% -- 63/519
2018-06-20 19:25:00,846:INFO: Hereditary Nonpolyposis Colorectal Cancer Recall-at-100: 45.00%
2018-06-20 19:25:00,846:INFO: Experiment Progress: 12.0% -- 64/519
2018-06-20 19:25:01,517:INFO: Acute Promyelocytic Leukemia Recall-at-100: 18.33%
2018-06-20 19:25:01,517:INFO: Experiment Progress: 12.0% -- 65/519
2018-06-20 19:25:01,976:INFO: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 10.00%
2018-06-20 19:25:01,976:INFO: Experiment Progress: 12.0% -- 66/519
2018-06-20 19:25:02,390:INFO: Gout Recall-at-100: 0.00%
2018-06-20 19:25:02,390:INFO: Experiment Progress: 12.0% -- 67/519
2018-06-20 19:25:03,400:INFO: Coronary Artery Disease Recall-at-100: 3.10%
2018-06-20 19:25:03,400:INFO: Experiment Progress: 13.0% -- 68/519
2018-06-20 19:25:04,062:INFO: Venous Thromboembolism Recall-at-100: 30.00%
2018-06-20 19:25:04,062:INFO: Experiment Progress: 13.0% -- 69/519
2018-06-20 19:25:05,478:INFO: Precancerous Conditions Recall-at-100: 4.29%
2018-06-20 19:25:05,479:INFO: Experiment Progress: 13.0% -- 70/519
2018-06-20 19:25:06,828:INFO: Crohn Disease Recall-at-100: 4.72%
2018-06-20 19:25:06,829:INFO: Experiment Progress: 13.0% -- 71/519
2018-06-20 19:25:07,521:INFO: Uterine Cervical Neoplasm Recall-at-100: 20.00%
2018-06-20 19:25:07,521:INFO: Experiment Progress: 13.0% -- 72/519
2018-06-20 19:25:08,140:INFO: Dyskinesia, Drug-Induced Recall-at-100: 40.00%
2018-06-20 19:25:08,140:INFO: Experiment Progress: 14.0% -- 73/519
2018-06-20 19:25:08,725:INFO: Ataxia, Spinocerebellar Recall-at-100: 30.00%
2018-06-20 19:25:08,726:INFO: Experiment Progress: 14.0% -- 74/519
2018-06-20 19:25:09,177:INFO: Optic Atrophy, Hereditary, Leber Recall-at-100: 70.00%
2018-06-20 19:25:09,177:INFO: Experiment Progress: 14.0% -- 75/519
2018-06-20 19:25:09,717:INFO: Liver Cirrhosis, Alcoholic Recall-at-100: 10.00%
2018-06-20 19:25:09,717:INFO: Experiment Progress: 14.0% -- 76/519
2018-06-20 19:25:10,310:INFO: Acute Lung Injury Recall-at-100: 0.00%
2018-06-20 19:25:10,311:INFO: Experiment Progress: 14.0% -- 77/519
2018-06-20 19:25:11,794:INFO: Liver Cirrhosis, Experimental Recall-at-100: 6.45%
2018-06-20 19:25:11,794:INFO: Experiment Progress: 15.0% -- 78/519
2018-06-20 19:25:12,484:INFO: Chloracne Recall-at-100: 18.33%
2018-06-20 19:25:12,484:INFO: Experiment Progress: 15.0% -- 79/519
2018-06-20 19:25:13,754:INFO: Liver diseases Recall-at-100: 3.33%
2018-06-20 19:25:13,754:INFO: Experiment Progress: 15.0% -- 80/519
2018-06-20 19:25:14,609:INFO: Kidney Failure, Chronic Recall-at-100: 16.00%
2018-06-20 19:25:14,609:INFO: Experiment Progress: 15.0% -- 81/519
2018-06-20 19:25:15,127:INFO: Weight decreased Recall-at-100: 0.00%
2018-06-20 19:25:15,127:INFO: Experiment Progress: 15.0% -- 82/519
2018-06-20 19:25:15,903:INFO: Leigh Disease Recall-at-100: 55.83%
2018-06-20 19:25:15,903:INFO: Experiment Progress: 15.0% -- 83/519
2018-06-20 19:25:16,867:INFO: Celiac Disease Recall-at-100: 12.50%
2018-06-20 19:25:16,868:INFO: Experiment Progress: 16.0% -- 84/519
2018-06-20 19:25:17,505:INFO: Glaucoma Recall-at-100: 0.00%
2018-06-20 19:25:17,505:INFO: Experiment Progress: 16.0% -- 85/519
2018-06-20 19:25:18,026:INFO: Tachycardia Recall-at-100: 40.00%
2018-06-20 19:25:18,026:INFO: Experiment Progress: 16.0% -- 86/519
2018-06-20 19:25:18,501:INFO: Breast Cancer, Familial Recall-at-100: 80.00%
2018-06-20 19:25:18,502:INFO: Experiment Progress: 16.0% -- 87/519
2018-06-20 19:25:19,103:INFO: Ischemia Recall-at-100: 8.33%
2018-06-20 19:25:19,103:INFO: Experiment Progress: 16.0% -- 88/519
2018-06-20 19:25:19,494:INFO: Adenomatous Polyposis Coli Recall-at-100: 0.00%
2018-06-20 19:25:19,494:INFO: Experiment Progress: 17.0% -- 89/519
2018-06-20 19:25:19,925:INFO: Thyroid Diseases Recall-at-100: 10.00%
2018-06-20 19:25:19,926:INFO: Experiment Progress: 17.0% -- 90/519
2018-06-20 19:25:20,243:INFO: Panic Disorder Recall-at-100: 0.00%
2018-06-20 19:25:20,243:INFO: Experiment Progress: 17.0% -- 91/519
2018-06-20 19:25:23,397:INFO: Colorectal Neoplasms Recall-at-100: 4.26%
2018-06-20 19:25:23,397:INFO: Experiment Progress: 17.0% -- 92/519
2018-06-20 19:25:23,910:INFO: Adrenal Gland Neoplasms Recall-at-100: 50.00%
2018-06-20 19:25:23,910:INFO: Experiment Progress: 17.0% -- 93/519
2018-06-20 19:25:24,426:INFO: Sudden infant death syndrome Recall-at-100: 30.00%
2018-06-20 19:25:24,426:INFO: Experiment Progress: 18.0% -- 94/519
2018-06-20 19:25:25,336:INFO: Neuroblastoma Recall-at-100: 11.00%
2018-06-20 19:25:25,336:INFO: Experiment Progress: 18.0% -- 95/519
2018-06-20 19:25:25,827:INFO: Prostate cancer, familial Recall-at-100: 15.00%
2018-06-20 19:25:25,827:INFO: Experiment Progress: 18.0% -- 96/519
2018-06-20 19:25:27,870:INFO: Animal Mammary Neoplasms Recall-at-100: 10.22%
2018-06-20 19:25:27,871:INFO: Experiment Progress: 18.0% -- 97/519
2018-06-20 19:25:28,357:INFO: Osteochondrodysplasias Recall-at-100: 30.00%
2018-06-20 19:25:28,357:INFO: Experiment Progress: 18.0% -- 98/519
2018-06-20 19:25:28,971:INFO: Hepatolenticular Degeneration Recall-at-100: 25.00%
2018-06-20 19:25:28,971:INFO: Experiment Progress: 19.0% -- 99/519
2018-06-20 19:25:29,578:INFO: Fanconi Anemia Recall-at-100: 80.00%
2018-06-20 19:25:29,578:INFO: Experiment Progress: 19.0% -- 100/519
2018-06-20 19:25:30,124:INFO: Eye Abnormalities Recall-at-100: 30.00%
2018-06-20 19:25:30,125:INFO: Experiment Progress: 19.0% -- 101/519
2018-06-20 19:25:30,664:INFO: Limb Deformities, Congenital Recall-at-100: 15.00%
2018-06-20 19:25:30,666:INFO: Experiment Progress: 19.0% -- 102/519
2018-06-20 19:25:31,092:INFO: Electrocardiogram: P-R interval Recall-at-100: 0.00%
2018-06-20 19:25:31,092:INFO: Experiment Progress: 19.0% -- 103/519
2018-06-20 19:25:33,281:INFO: Mammary Neoplasms, Experimental Recall-at-100: 7.96%
2018-06-20 19:25:33,282:INFO: Experiment Progress: 20.0% -- 104/519
2018-06-20 19:25:33,961:INFO: Heart valve disease Recall-at-100: 3.33%
2018-06-20 19:25:33,961:INFO: Experiment Progress: 20.0% -- 105/519
2018-06-20 19:25:34,693:INFO: Diffuse Large B-Cell Lymphoma Recall-at-100: 5.00%
2018-06-20 19:25:34,693:INFO: Experiment Progress: 20.0% -- 106/519
2018-06-20 19:25:35,217:INFO: Hepatitis Recall-at-100: 0.00%
2018-06-20 19:25:35,217:INFO: Experiment Progress: 20.0% -- 107/519
2018-06-20 19:25:35,737:INFO: Impaired glucose tolerance Recall-at-100: 15.00%
2018-06-20 19:25:35,738:INFO: Experiment Progress: 20.0% -- 108/519
2018-06-20 19:25:36,188:INFO: Mitochondrial Encephalomyopathies Recall-at-100: 25.00%
2018-06-20 19:25:36,189:INFO: Experiment Progress: 21.0% -- 109/519
2018-06-20 19:25:36,885:INFO: Colon Carcinoma Recall-at-100: 20.00%
2018-06-20 19:25:36,885:INFO: Experiment Progress: 21.0% -- 110/519
2018-06-20 19:25:37,416:INFO: Hepatic Encephalopathy Recall-at-100: 40.00%
2018-06-20 19:25:37,416:INFO: Experiment Progress: 21.0% -- 111/519
2018-06-20 19:25:38,824:INFO: Multiple Sclerosis Recall-at-100: 5.69%
2018-06-20 19:25:38,824:INFO: Experiment Progress: 21.0% -- 112/519
2018-06-20 19:25:39,345:INFO: Neurogenic Inflammation Recall-at-100: 20.00%
2018-06-20 19:25:39,346:INFO: Experiment Progress: 21.0% -- 113/519
2018-06-20 19:25:40,552:INFO: Lupus Erythematosus, Systemic Recall-at-100: 5.71%
2018-06-20 19:25:40,552:INFO: Experiment Progress: 21.0% -- 114/519
2018-06-20 19:25:41,002:INFO: Ceroid lipofuscinosis, neuronal 1, infantile Recall-at-100: 10.00%
2018-06-20 19:25:41,003:INFO: Experiment Progress: 22.0% -- 115/519
2018-06-20 19:25:41,849:INFO: Adenocarcinoma of lung (disorder) Recall-at-100: 7.00%
2018-06-20 19:25:41,849:INFO: Experiment Progress: 22.0% -- 116/519
2018-06-20 19:25:42,486:INFO: Charcot-Marie-Tooth Disease Recall-at-100: 5.00%
2018-06-20 19:25:42,486:INFO: Experiment Progress: 22.0% -- 117/519
2018-06-20 19:25:43,002:INFO: Osteogenesis imperfecta type III (disorder) Recall-at-100: 45.00%
2018-06-20 19:25:43,003:INFO: Experiment Progress: 22.0% -- 118/519
2018-06-20 19:25:43,434:INFO: Osteogenesis imperfecta type IV (disorder) Recall-at-100: 30.00%
2018-06-20 19:25:43,435:INFO: Experiment Progress: 22.0% -- 119/519
2018-06-20 19:25:43,989:INFO: Hepatitis, Autoimmune Recall-at-100: 15.00%
2018-06-20 19:25:43,989:INFO: Experiment Progress: 23.0% -- 120/519
2018-06-20 19:25:49,442:INFO: Prostatic Neoplasms Recall-at-100: 5.34%
2018-06-20 19:25:49,443:INFO: Experiment Progress: 23.0% -- 121/519
2018-06-20 19:25:50,040:INFO: NADH:Q(1) Oxidoreductase deficiency Recall-at-100: 85.00%
2018-06-20 19:25:50,040:INFO: Experiment Progress: 23.0% -- 122/519
2018-06-20 19:25:50,554:INFO: Hypospadias Recall-at-100: 0.00%
2018-06-20 19:25:50,554:INFO: Experiment Progress: 23.0% -- 123/519
2018-06-20 19:25:51,323:INFO: Multiple Myeloma Recall-at-100: 13.33%
2018-06-20 19:25:51,324:INFO: Experiment Progress: 23.0% -- 124/519
2018-06-20 19:25:52,205:INFO: Fatty Liver Recall-at-100: 10.00%
2018-06-20 19:25:52,205:INFO: Experiment Progress: 24.0% -- 125/519
2018-06-20 19:25:52,655:INFO: Leishmaniasis, Visceral Recall-at-100: 30.00%
2018-06-20 19:25:52,656:INFO: Experiment Progress: 24.0% -- 126/519
2018-06-20 19:25:53,242:INFO: Early infantile epileptic encephalopathy with suppression bursts Recall-at-100: 5.00%
2018-06-20 19:25:53,242:INFO: Experiment Progress: 24.0% -- 127/519
2018-06-20 19:25:53,836:INFO: Kartagener Syndrome Recall-at-100: 5.00%
2018-06-20 19:25:53,836:INFO: Experiment Progress: 24.0% -- 128/519
2018-06-20 19:25:54,358:INFO: Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse Recall-at-100: 45.00%
2018-06-20 19:25:54,359:INFO: Experiment Progress: 24.0% -- 129/519
2018-06-20 19:25:55,485:INFO: Bipolar Disorder Recall-at-100: 10.00%
2018-06-20 19:25:55,485:INFO: Experiment Progress: 25.0% -- 130/519
2018-06-20 19:25:55,980:INFO: Erectile dysfunction Recall-at-100: 40.00%
2018-06-20 19:25:55,980:INFO: Experiment Progress: 25.0% -- 131/519
2018-06-20 19:25:56,502:INFO: Meckel-Gruber syndrome Recall-at-100: 90.00%
2018-06-20 19:25:56,502:INFO: Experiment Progress: 25.0% -- 132/519
2018-06-20 19:25:58,371:INFO: Colonic Neoplasms Recall-at-100: 11.99%
2018-06-20 19:25:58,371:INFO: Experiment Progress: 25.0% -- 133/519
2018-06-20 19:26:01,328:INFO: Autistic Disorder Recall-at-100: 2.97%
2018-06-20 19:26:01,328:INFO: Experiment Progress: 25.0% -- 134/519
2018-06-20 19:26:02,396:INFO: Liver Neoplasms, Experimental Recall-at-100: 9.33%
2018-06-20 19:26:02,396:INFO: Experiment Progress: 26.0% -- 135/519
2018-06-20 19:26:02,954:INFO: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Recall-at-100: 5.00%
2018-06-20 19:26:02,954:INFO: Experiment Progress: 26.0% -- 136/519
2018-06-20 19:26:03,472:INFO: Narcolepsy Recall-at-100: 25.00%
2018-06-20 19:26:03,472:INFO: Experiment Progress: 26.0% -- 137/519
2018-06-20 19:26:03,998:INFO: Fever Recall-at-100: 15.00%
2018-06-20 19:26:03,999:INFO: Experiment Progress: 26.0% -- 138/519
2018-06-20 19:26:05,588:INFO: Adenocarcinoma Recall-at-100: 13.27%
2018-06-20 19:26:05,589:INFO: Experiment Progress: 26.0% -- 139/519
2018-06-20 19:26:06,207:INFO: Aortic Valve Insufficiency Recall-at-100: 70.00%
2018-06-20 19:26:06,207:INFO: Experiment Progress: 26.0% -- 140/519
2018-06-20 19:26:06,817:INFO: Carcinoma, Pancreatic Ductal Recall-at-100: 45.00%
2018-06-20 19:26:06,818:INFO: Experiment Progress: 27.0% -- 141/519
2018-06-20 19:26:07,445:INFO: Infarction, Middle Cerebral Artery Recall-at-100: 23.33%
2018-06-20 19:26:07,445:INFO: Experiment Progress: 27.0% -- 142/519
2018-06-20 19:26:09,965:INFO: Hypertensive disease Recall-at-100: 6.87%
2018-06-20 19:26:09,965:INFO: Experiment Progress: 27.0% -- 143/519
2018-06-20 19:26:10,550:INFO: Juvenile Myelomonocytic Leukemia Recall-at-100: 30.00%
2018-06-20 19:26:10,551:INFO: Experiment Progress: 27.0% -- 144/519
2018-06-20 19:26:11,139:INFO: Leprosy Recall-at-100: 5.00%
2018-06-20 19:26:11,139:INFO: Experiment Progress: 27.0% -- 145/519
2018-06-20 19:26:12,572:INFO: Myocardial Infarction Recall-at-100: 4.58%
2018-06-20 19:26:12,572:INFO: Experiment Progress: 28.0% -- 146/519
2018-06-20 19:26:13,102:INFO: Urticaria Recall-at-100: 5.00%
2018-06-20 19:26:13,102:INFO: Experiment Progress: 28.0% -- 147/519
2018-06-20 19:26:13,699:INFO: Cardiac Arrhythmia Recall-at-100: 15.00%
2018-06-20 19:26:13,699:INFO: Experiment Progress: 28.0% -- 148/519
2018-06-20 19:26:14,160:INFO: Hemochromatosis Recall-at-100: 65.00%
2018-06-20 19:26:14,160:INFO: Experiment Progress: 28.0% -- 149/519
2018-06-20 19:26:15,447:INFO: Pancreatic Neoplasm Recall-at-100: 15.00%
2018-06-20 19:26:15,448:INFO: Experiment Progress: 28.0% -- 150/519
2018-06-20 19:26:16,387:INFO: Cardiomyopathy, Dilated Recall-at-100: 24.50%
2018-06-20 19:26:16,387:INFO: Experiment Progress: 29.0% -- 151/519
2018-06-20 19:26:16,853:INFO: Papilloma Recall-at-100: 20.00%
2018-06-20 19:26:16,854:INFO: Experiment Progress: 29.0% -- 152/519
2018-06-20 19:26:17,655:INFO: Pain Recall-at-100: 14.00%
2018-06-20 19:26:17,655:INFO: Experiment Progress: 29.0% -- 153/519
2018-06-20 19:26:18,101:INFO: Congenital Abnormality Recall-at-100: 30.00%
2018-06-20 19:26:18,102:INFO: Experiment Progress: 29.0% -- 154/519
2018-06-20 19:26:18,521:INFO: MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) Recall-at-100: 40.00%
2018-06-20 19:26:18,522:INFO: Experiment Progress: 29.0% -- 155/519
2018-06-20 19:26:19,857:INFO: Kidney Diseases Recall-at-100: 3.61%
2018-06-20 19:26:19,857:INFO: Experiment Progress: 30.0% -- 156/519
2018-06-20 19:26:20,391:INFO: Lung Diseases, Interstitial Recall-at-100: 0.00%
2018-06-20 19:26:20,391:INFO: Experiment Progress: 30.0% -- 157/519
2018-06-20 19:26:20,997:INFO: Basal cell carcinoma Recall-at-100: 20.00%
2018-06-20 19:26:20,997:INFO: Experiment Progress: 30.0% -- 158/519
2018-06-20 19:26:23,732:INFO: Liver carcinoma Recall-at-100: 10.13%
2018-06-20 19:26:23,732:INFO: Experiment Progress: 30.0% -- 159/519
2018-06-20 19:26:24,217:INFO: gliosarcoma Recall-at-100: 25.00%
2018-06-20 19:26:24,217:INFO: Experiment Progress: 30.0% -- 160/519
2018-06-20 19:26:24,889:INFO: Acute Coronary Syndrome Recall-at-100: 22.50%
2018-06-20 19:26:24,890:INFO: Experiment Progress: 31.0% -- 161/519
2018-06-20 19:26:25,606:INFO: Ovarian Cysts Recall-at-100: 0.00%
2018-06-20 19:26:25,607:INFO: Experiment Progress: 31.0% -- 162/519
2018-06-20 19:26:26,112:INFO: Schizophrenia, Childhood Recall-at-100: 0.00%
2018-06-20 19:26:26,112:INFO: Experiment Progress: 31.0% -- 163/519
2018-06-20 19:26:26,656:INFO: Adrenocortical carcinoma Recall-at-100: 30.00%
2018-06-20 19:26:26,657:INFO: Experiment Progress: 31.0% -- 164/519
2018-06-20 19:26:29,797:INFO: Schizophrenia Recall-at-100: 2.10%
2018-06-20 19:26:29,797:INFO: Experiment Progress: 31.0% -- 165/519
2018-06-20 19:26:30,285:INFO: Atrophic Recall-at-100: 0.00%
2018-06-20 19:26:30,285:INFO: Experiment Progress: 31.0% -- 166/519
2018-06-20 19:26:30,786:INFO: Idiopathic Pulmonary Fibrosis Recall-at-100: 30.00%
2018-06-20 19:26:30,787:INFO: Experiment Progress: 32.0% -- 167/519
2018-06-20 19:26:31,318:INFO: Lobar Holoprosencephaly Recall-at-100: 40.00%
2018-06-20 19:26:31,318:INFO: Experiment Progress: 32.0% -- 168/519
2018-06-20 19:26:31,801:INFO: Alobar Holoprosencephaly Recall-at-100: 40.00%
2018-06-20 19:26:31,801:INFO: Experiment Progress: 32.0% -- 169/519
2018-06-20 19:26:32,367:INFO: Immunologic Deficiency Syndromes Recall-at-100: 45.00%
2018-06-20 19:26:32,367:INFO: Experiment Progress: 32.0% -- 170/519
2018-06-20 19:26:32,880:INFO: Ataxia Recall-at-100: 25.00%
2018-06-20 19:26:32,880:INFO: Experiment Progress: 32.0% -- 171/519
2018-06-20 19:26:33,362:INFO: Adenocarcinoma Of Esophagus Recall-at-100: 10.00%
2018-06-20 19:26:33,362:INFO: Experiment Progress: 33.0% -- 172/519
2018-06-20 19:26:34,483:INFO: Retinitis Pigmentosa Recall-at-100: 15.71%
2018-06-20 19:26:34,483:INFO: Experiment Progress: 33.0% -- 173/519
2018-06-20 19:26:35,863:INFO: Squamous cell carcinoma of esophagus Recall-at-100: 8.75%
2018-06-20 19:26:35,864:INFO: Experiment Progress: 33.0% -- 174/519
2018-06-20 19:26:36,738:INFO: Autoimmune Diseases Recall-at-100: 0.00%
2018-06-20 19:26:36,739:INFO: Experiment Progress: 33.0% -- 175/519
2018-06-20 19:26:37,193:INFO: Diarrhea Recall-at-100: 10.00%
2018-06-20 19:26:37,193:INFO: Experiment Progress: 33.0% -- 176/519
2018-06-20 19:26:39,311:INFO: Myocardial Ischemia Recall-at-100: 3.01%
2018-06-20 19:26:39,311:INFO: Experiment Progress: 34.0% -- 177/519
2018-06-20 19:26:39,816:INFO: Essential Hypertension Recall-at-100: 10.00%
2018-06-20 19:26:39,816:INFO: Experiment Progress: 34.0% -- 178/519
2018-06-20 19:26:40,219:INFO: Hepatomegaly Recall-at-100: 33.33%
2018-06-20 19:26:40,220:INFO: Experiment Progress: 34.0% -- 179/519
2018-06-20 19:26:40,849:INFO: Myopathy Recall-at-100: 0.00%
2018-06-20 19:26:40,849:INFO: Experiment Progress: 34.0% -- 180/519
2018-06-20 19:26:41,840:INFO: Adverse reaction to drug Recall-at-100: 11.00%
2018-06-20 19:26:41,840:INFO: Experiment Progress: 34.0% -- 181/519
2018-06-20 19:26:42,314:INFO: Myoclonic Epilepsies, Progressive Recall-at-100: 15.00%
2018-06-20 19:26:42,315:INFO: Experiment Progress: 35.0% -- 182/519
2018-06-20 19:26:42,861:INFO: Muscular Atrophy Recall-at-100: 15.00%
2018-06-20 19:26:42,861:INFO: Experiment Progress: 35.0% -- 183/519
2018-06-20 19:26:43,341:INFO: Basal Ganglia Diseases Recall-at-100: 20.00%
2018-06-20 19:26:43,341:INFO: Experiment Progress: 35.0% -- 184/519
2018-06-20 19:26:43,861:INFO: Hepatitis B Recall-at-100: 35.00%
2018-06-20 19:26:43,862:INFO: Experiment Progress: 35.0% -- 185/519
2018-06-20 19:26:44,638:INFO: Lung diseases Recall-at-100: 4.00%
2018-06-20 19:26:44,639:INFO: Experiment Progress: 35.0% -- 186/519
2018-06-20 19:26:45,483:INFO: Chronic Obstructive Airway Disease Recall-at-100: 5.00%
2018-06-20 19:26:45,483:INFO: Experiment Progress: 36.0% -- 187/519
2018-06-20 19:26:48,963:INFO: Peripheral Neuropathy Recall-at-100: 2.17%
2018-06-20 19:26:48,964:INFO: Experiment Progress: 36.0% -- 188/519
2018-06-20 19:26:50,239:INFO: Weight Gain Recall-at-100: 6.81%
2018-06-20 19:26:50,239:INFO: Experiment Progress: 36.0% -- 189/519
2018-06-20 19:26:50,810:INFO: Deafness Recall-at-100: 0.00%
2018-06-20 19:26:50,810:INFO: Experiment Progress: 36.0% -- 190/519
2018-06-20 19:26:51,257:INFO: Renal dysplasia and retinal aplasia (disorder) Recall-at-100: 50.00%
2018-06-20 19:26:51,257:INFO: Experiment Progress: 36.0% -- 191/519
2018-06-20 19:26:51,997:INFO: Attention deficit hyperactivity disorder Recall-at-100: 13.33%
2018-06-20 19:26:51,997:INFO: Experiment Progress: 36.0% -- 192/519
2018-06-20 19:26:52,497:INFO: Tetralogy of Fallot Recall-at-100: 50.00%
2018-06-20 19:26:52,497:INFO: Experiment Progress: 37.0% -- 193/519
2018-06-20 19:26:53,254:INFO: Neurodegenerative Disorders Recall-at-100: 17.50%
2018-06-20 19:26:53,254:INFO: Experiment Progress: 37.0% -- 194/519
2018-06-20 19:26:53,723:INFO: Barrett Esophagus Recall-at-100: 20.00%
2018-06-20 19:26:53,723:INFO: Experiment Progress: 37.0% -- 195/519
2018-06-20 19:26:55,662:INFO: Craniofacial Abnormalities Recall-at-100: 6.29%
2018-06-20 19:26:55,662:INFO: Experiment Progress: 37.0% -- 196/519
2018-06-20 19:26:56,181:INFO: Necrotizing Enterocolitis Recall-at-100: 30.00%
2018-06-20 19:26:56,182:INFO: Experiment Progress: 37.0% -- 197/519
2018-06-20 19:26:56,666:INFO: Hyperlipidemia Recall-at-100: 35.00%
2018-06-20 19:26:56,666:INFO: Experiment Progress: 38.0% -- 198/519
2018-06-20 19:26:57,259:INFO: MYELODYSPLASTIC SYNDROME Recall-at-100: 5.00%
2018-06-20 19:26:57,260:INFO: Experiment Progress: 38.0% -- 199/519
2018-06-20 19:26:57,976:INFO: Anoxia Recall-at-100: 5.83%
2018-06-20 19:26:57,976:INFO: Experiment Progress: 38.0% -- 200/519
2018-06-20 19:26:58,792:INFO: Small cell carcinoma of lung Recall-at-100: 20.00%
2018-06-20 19:26:58,792:INFO: Experiment Progress: 38.0% -- 201/519
2018-06-20 19:26:59,900:INFO: Epilepsy Recall-at-100: 7.86%
2018-06-20 19:26:59,901:INFO: Experiment Progress: 38.0% -- 202/519
2018-06-20 19:27:00,505:INFO: Liver Failure, Acute Recall-at-100: 16.67%
2018-06-20 19:27:00,505:INFO: Experiment Progress: 39.0% -- 203/519
2018-06-20 19:27:01,033:INFO: Micronuclei, Chromosome-Defective Recall-at-100: 20.00%
2018-06-20 19:27:01,033:INFO: Experiment Progress: 39.0% -- 204/519
2018-06-20 19:27:01,720:INFO: Cognition Disorders Recall-at-100: 5.00%
2018-06-20 19:27:01,721:INFO: Experiment Progress: 39.0% -- 205/519
2018-06-20 19:27:02,231:INFO: Tonic-Clonic Epilepsy Recall-at-100: 30.00%
2018-06-20 19:27:02,231:INFO: Experiment Progress: 39.0% -- 206/519
2018-06-20 19:27:03,020:INFO: Heart Diseases Recall-at-100: 7.00%
2018-06-20 19:27:03,020:INFO: Experiment Progress: 39.0% -- 207/519
2018-06-20 19:27:04,115:INFO: Adult T-Cell Lymphoma/Leukemia Recall-at-100: 16.67%
2018-06-20 19:27:04,115:INFO: Experiment Progress: 40.0% -- 208/519
2018-06-20 19:27:04,853:INFO: Primary biliary cirrhosis Recall-at-100: 30.00%
2018-06-20 19:27:04,854:INFO: Experiment Progress: 40.0% -- 209/519
2018-06-20 19:27:05,349:INFO: beta Thalassemia Recall-at-100: 20.00%
2018-06-20 19:27:05,349:INFO: Experiment Progress: 40.0% -- 210/519
2018-06-20 19:27:05,768:INFO: Marijuana Abuse Recall-at-100: 20.00%
2018-06-20 19:27:05,768:INFO: Experiment Progress: 40.0% -- 211/519
2018-06-20 19:27:06,246:INFO: Long QT Syndrome Recall-at-100: 60.00%
2018-06-20 19:27:06,247:INFO: Experiment Progress: 40.0% -- 212/519
2018-06-20 19:27:06,751:INFO: Burkitt Lymphoma Recall-at-100: 20.00%
2018-06-20 19:27:06,752:INFO: Experiment Progress: 41.0% -- 213/519
2018-06-20 19:27:07,166:INFO: TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) Recall-at-100: 30.00%
2018-06-20 19:27:07,166:INFO: Experiment Progress: 41.0% -- 214/519
2018-06-20 19:27:08,060:INFO: Insulin Resistance Recall-at-100: 20.50%
2018-06-20 19:27:08,061:INFO: Experiment Progress: 41.0% -- 215/519
2018-06-20 19:27:08,664:INFO: Left Ventricular Hypertrophy Recall-at-100: 38.33%
2018-06-20 19:27:08,664:INFO: Experiment Progress: 41.0% -- 216/519
2018-06-20 19:27:09,115:INFO: Bronchial Hyperreactivity Recall-at-100: 5.00%
2018-06-20 19:27:09,115:INFO: Experiment Progress: 41.0% -- 217/519
2018-06-20 19:27:10,016:INFO: AMYOTROPHIC LATERAL SCLEROSIS 1 Recall-at-100: 10.50%
2018-06-20 19:27:10,017:INFO: Experiment Progress: 42.0% -- 218/519
2018-06-20 19:27:10,520:INFO: Fetal Growth Retardation Recall-at-100: 20.00%
2018-06-20 19:27:10,520:INFO: Experiment Progress: 42.0% -- 219/519
2018-06-20 19:27:10,855:INFO: Holoprosencephaly Recall-at-100: 37.50%
2018-06-20 19:27:10,856:INFO: Experiment Progress: 42.0% -- 220/519
2018-06-20 19:27:11,544:INFO: Arthritis, Experimental Recall-at-100: 17.50%
2018-06-20 19:27:11,544:INFO: Experiment Progress: 42.0% -- 221/519
2018-06-20 19:27:12,313:INFO: Congenital Heart Defects Recall-at-100: 11.67%
2018-06-20 19:27:12,313:INFO: Experiment Progress: 42.0% -- 222/519
2018-06-20 19:27:12,771:INFO: Pseudohypoaldosteronism Recall-at-100: 66.67%
2018-06-20 19:27:12,771:INFO: Experiment Progress: 42.0% -- 223/519
2018-06-20 19:27:13,374:INFO: Cataract Recall-at-100: 31.67%
2018-06-20 19:27:13,375:INFO: Experiment Progress: 43.0% -- 224/519
2018-06-20 19:27:13,882:INFO: Giant Cell Glioblastoma Recall-at-100: 35.00%
2018-06-20 19:27:13,882:INFO: Experiment Progress: 43.0% -- 225/519
2018-06-20 19:27:14,506:INFO: Seizure Adverse Event Recall-at-100: 0.00%
2018-06-20 19:27:14,506:INFO: Experiment Progress: 43.0% -- 226/519
2018-06-20 19:27:14,986:INFO: Body Weight Recall-at-100: 0.00%
2018-06-20 19:27:14,987:INFO: Experiment Progress: 43.0% -- 227/519
2018-06-20 19:27:15,489:INFO: Huntington Disease Recall-at-100: 0.00%
2018-06-20 19:27:15,489:INFO: Experiment Progress: 43.0% -- 228/519
2018-06-20 19:27:16,595:INFO: Glioblastoma Recall-at-100: 11.43%
2018-06-20 19:27:16,595:INFO: Experiment Progress: 44.0% -- 229/519
2018-06-20 19:27:17,071:INFO: Congenital diaphragmatic hernia Recall-at-100: 25.00%
2018-06-20 19:27:17,071:INFO: Experiment Progress: 44.0% -- 230/519
2018-06-20 19:27:17,691:INFO: Systemic Scleroderma Recall-at-100: 0.00%
2018-06-20 19:27:17,691:INFO: Experiment Progress: 44.0% -- 231/519
2018-06-20 19:27:18,873:INFO: Acute kidney injury Recall-at-100: 10.48%
2018-06-20 19:27:18,873:INFO: Experiment Progress: 44.0% -- 232/519
2018-06-20 19:27:19,398:INFO: Copper-Overload Cirrhosis Recall-at-100: 10.00%
2018-06-20 19:27:19,398:INFO: Experiment Progress: 44.0% -- 233/519
2018-06-20 19:27:20,931:INFO: Spontaneous abortion Recall-at-100: 7.73%
2018-06-20 19:27:20,931:INFO: Experiment Progress: 45.0% -- 234/519
2018-06-20 19:27:21,976:INFO: Glioma Recall-at-100: 7.86%
2018-06-20 19:27:21,976:INFO: Experiment Progress: 45.0% -- 235/519
2018-06-20 19:27:22,456:INFO: Gliosis Recall-at-100: 50.00%
2018-06-20 19:27:22,457:INFO: Experiment Progress: 45.0% -- 236/519
2018-06-20 19:27:22,911:INFO: LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY Recall-at-100: 80.00%
2018-06-20 19:27:22,911:INFO: Experiment Progress: 45.0% -- 237/519
2018-06-20 19:27:23,328:INFO: Dementia Recall-at-100: 0.00%
2018-06-20 19:27:23,328:INFO: Experiment Progress: 45.0% -- 238/519
2018-06-20 19:27:23,870:INFO: Pancreatitis Recall-at-100: 0.00%
2018-06-20 19:27:23,870:INFO: Experiment Progress: 46.0% -- 239/519
2018-06-20 19:27:24,329:INFO: Amino Acid Metabolism, Inborn Errors Recall-at-100: 0.00%
2018-06-20 19:27:24,329:INFO: Experiment Progress: 46.0% -- 240/519
2018-06-20 19:27:25,006:INFO: Thyroid Neoplasm Recall-at-100: 10.00%
2018-06-20 19:27:25,006:INFO: Experiment Progress: 46.0% -- 241/519
2018-06-20 19:27:26,667:INFO: Neoplasm Invasiveness Recall-at-100: 13.53%
2018-06-20 19:27:26,667:INFO: Experiment Progress: 46.0% -- 242/519
2018-06-20 19:27:28,409:INFO: Neoplasm Metastasis Recall-at-100: 12.97%
2018-06-20 19:27:28,409:INFO: Experiment Progress: 46.0% -- 243/519
2018-06-20 19:27:28,926:INFO: Albuminuria Recall-at-100: 20.00%
2018-06-20 19:27:28,926:INFO: Experiment Progress: 47.0% -- 244/519
2018-06-20 19:27:29,429:INFO: Pre-Eclampsia Recall-at-100: 10.00%
2018-06-20 19:27:29,430:INFO: Experiment Progress: 47.0% -- 245/519
2018-06-20 19:27:30,509:INFO: Nerve Degeneration Recall-at-100: 13.57%
2018-06-20 19:27:30,509:INFO: Experiment Progress: 47.0% -- 246/519
2018-06-20 19:27:30,986:INFO: Thromboembolism Recall-at-100: 85.00%
2018-06-20 19:27:30,986:INFO: Experiment Progress: 47.0% -- 247/519
2018-06-20 19:27:32,848:INFO: Polycystic Ovary Syndrome Recall-at-100: 1.38%
2018-06-20 19:27:32,849:INFO: Experiment Progress: 47.0% -- 248/519
2018-06-20 19:27:33,260:INFO: Transient Ischemic Attack Recall-at-100: 30.00%
2018-06-20 19:27:33,261:INFO: Experiment Progress: 47.0% -- 249/519
2018-06-20 19:27:34,153:INFO: Brain Ischemia Recall-at-100: 21.67%
2018-06-20 19:27:34,153:INFO: Experiment Progress: 48.0% -- 250/519
2018-06-20 19:27:34,563:INFO: Cerebral Infarction Recall-at-100: 40.00%
2018-06-20 19:27:34,563:INFO: Experiment Progress: 48.0% -- 251/519
2018-06-20 19:27:35,071:INFO: Malignant neoplasm of esophagus Recall-at-100: 20.00%
2018-06-20 19:27:35,071:INFO: Experiment Progress: 48.0% -- 252/519
2018-06-20 19:27:36,408:INFO: Degenerative polyarthritis Recall-at-100: 9.78%
2018-06-20 19:27:36,408:INFO: Experiment Progress: 48.0% -- 253/519
2018-06-20 19:27:36,728:INFO: Osteitis Deformans Recall-at-100: 12.50%
2018-06-20 19:27:36,729:INFO: Experiment Progress: 48.0% -- 254/519
2018-06-20 19:27:37,134:INFO: Diabetic Cardiomyopathies Recall-at-100: 0.00%
2018-06-20 19:27:37,135:INFO: Experiment Progress: 49.0% -- 255/519
2018-06-20 19:27:37,569:INFO: Nuclear cataract Recall-at-100: 50.00%
2018-06-20 19:27:37,570:INFO: Experiment Progress: 49.0% -- 256/519
2018-06-20 19:27:38,039:INFO: Anorexia Recall-at-100: 55.00%
2018-06-20 19:27:38,039:INFO: Experiment Progress: 49.0% -- 257/519
2018-06-20 19:27:39,238:INFO: Cocaine-Related Disorders Recall-at-100: 13.06%
2018-06-20 19:27:39,238:INFO: Experiment Progress: 49.0% -- 258/519
2018-06-20 19:27:39,651:INFO: MELAS Syndrome Recall-at-100: 80.00%
2018-06-20 19:27:39,651:INFO: Experiment Progress: 49.0% -- 259/519
2018-06-20 19:27:39,880:INFO: Mitochondrial Myopathies Recall-at-100: 33.33%
2018-06-20 19:27:39,881:INFO: Experiment Progress: 50.0% -- 260/519
2018-06-20 19:27:40,961:INFO: Amphetamine-Related Disorders Recall-at-100: 1.43%
2018-06-20 19:27:40,961:INFO: Experiment Progress: 50.0% -- 261/519
2018-06-20 19:27:41,399:INFO: Birth Weight Recall-at-100: 0.00%
2018-06-20 19:27:41,399:INFO: Experiment Progress: 50.0% -- 262/519
2018-06-20 19:27:41,953:INFO: Brain Diseases Recall-at-100: 8.33%
2018-06-20 19:27:41,953:INFO: Experiment Progress: 50.0% -- 263/519
2018-06-20 19:27:42,414:INFO: Dyslipidemias Recall-at-100: 35.00%
2018-06-20 19:27:42,415:INFO: Experiment Progress: 50.0% -- 264/519
2018-06-20 19:27:42,770:INFO: Berylliosis Recall-at-100: 0.00%
2018-06-20 19:27:42,770:INFO: Experiment Progress: 51.0% -- 265/519
2018-06-20 19:27:43,266:INFO: Mental Retardation, X-Linked Recall-at-100: 0.00%
2018-06-20 19:27:43,266:INFO: Experiment Progress: 51.0% -- 266/519
2018-06-20 19:27:43,577:INFO: Sarcoidosis Recall-at-100: 25.00%
2018-06-20 19:27:43,577:INFO: Experiment Progress: 51.0% -- 267/519
2018-06-20 19:27:45,056:INFO: Liver neoplasms Recall-at-100: 8.64%
2018-06-20 19:27:45,057:INFO: Experiment Progress: 51.0% -- 268/519
2018-06-20 19:27:45,741:INFO: Myocardial Reperfusion Injury Recall-at-100: 20.83%
2018-06-20 19:27:45,741:INFO: Experiment Progress: 51.0% -- 269/519
2018-06-20 19:27:46,214:INFO: Microsatellite Instability Recall-at-100: 0.00%
2018-06-20 19:27:46,214:INFO: Experiment Progress: 52.0% -- 270/519
2018-06-20 19:27:46,629:INFO: Night blindness, congenital stationary Recall-at-100: 45.00%
2018-06-20 19:27:46,629:INFO: Experiment Progress: 52.0% -- 271/519
2018-06-20 19:27:47,260:INFO: Stevens-Johnson Syndrome Recall-at-100: 26.67%
2018-06-20 19:27:47,260:INFO: Experiment Progress: 52.0% -- 272/519
2018-06-20 19:27:47,688:INFO: Leukemia, Lymphocytic, Acute, L1 Recall-at-100: 0.00%
2018-06-20 19:27:47,688:INFO: Experiment Progress: 52.0% -- 273/519
2018-06-20 19:27:48,555:INFO: Systemic arterial pressure Recall-at-100: 0.00%
2018-06-20 19:27:48,556:INFO: Experiment Progress: 52.0% -- 274/519
2018-06-20 19:27:49,155:INFO: Learning Disorders Recall-at-100: 10.00%
2018-06-20 19:27:49,155:INFO: Experiment Progress: 52.0% -- 275/519
2018-06-20 19:27:49,586:INFO: Walker-Warburg congenital muscular dystrophy Recall-at-100: 60.00%
2018-06-20 19:27:49,587:INFO: Experiment Progress: 53.0% -- 276/519
2018-06-20 19:27:50,016:INFO: Marfan Syndrome Recall-at-100: 50.00%
2018-06-20 19:27:50,017:INFO: Experiment Progress: 53.0% -- 277/519
2018-06-20 19:27:50,471:INFO: Congenital ocular coloboma (disorder) Recall-at-100: 10.00%
2018-06-20 19:27:50,471:INFO: Experiment Progress: 53.0% -- 278/519
2018-06-20 19:27:52,744:INFO: Lung Neoplasms Recall-at-100: 11.57%
2018-06-20 19:27:52,744:INFO: Experiment Progress: 53.0% -- 279/519
2018-06-20 19:27:53,052:INFO: Myoclonic Epilepsy, Juvenile Recall-at-100: 0.00%
2018-06-20 19:27:53,053:INFO: Experiment Progress: 53.0% -- 280/519
2018-06-20 19:27:54,507:INFO: Inflammatory Bowel Diseases Recall-at-100: 2.50%
2018-06-20 19:27:54,508:INFO: Experiment Progress: 54.0% -- 281/519
2018-06-20 19:27:58,994:INFO: Mammary Neoplasms Recall-at-100: 6.87%
2018-06-20 19:27:58,994:INFO: Experiment Progress: 54.0% -- 282/519
2018-06-20 19:27:59,215:INFO: Idiopathic generalized epilepsy Recall-at-100: 0.00%
2018-06-20 19:27:59,216:INFO: Experiment Progress: 54.0% -- 283/519
2018-06-20 19:27:59,664:INFO: Neuralgia Recall-at-100: 0.00%
2018-06-20 19:27:59,664:INFO: Experiment Progress: 54.0% -- 284/519
2018-06-20 19:28:00,266:INFO: Neural Tube Defects Recall-at-100: 16.67%
2018-06-20 19:28:00,266:INFO: Experiment Progress: 54.0% -- 285/519
2018-06-20 19:28:01,317:INFO: Dermatitis, Allergic Contact Recall-at-100: 0.00%
2018-06-20 19:28:01,317:INFO: Experiment Progress: 55.0% -- 286/519
2018-06-20 19:28:01,800:INFO: Inborn Errors of Metabolism Recall-at-100: 10.00%
2018-06-20 19:28:01,800:INFO: Experiment Progress: 55.0% -- 287/519
2018-06-20 19:28:02,485:INFO: Platelet mean volume finding Recall-at-100: 0.00%
2018-06-20 19:28:02,485:INFO: Experiment Progress: 55.0% -- 288/519
2018-06-20 19:28:02,955:INFO: Intestinal Neoplasms Recall-at-100: 55.00%
2018-06-20 19:28:02,955:INFO: Experiment Progress: 55.0% -- 289/519
2018-06-20 19:28:03,399:INFO: Allergic rhinitis (disorder) Recall-at-100: 0.00%
2018-06-20 19:28:03,399:INFO: Experiment Progress: 55.0% -- 290/519
2018-06-20 19:28:04,233:INFO: Blood pressure finding Recall-at-100: 0.00%
2018-06-20 19:28:04,233:INFO: Experiment Progress: 56.0% -- 291/519
2018-06-20 19:28:04,966:INFO: Age related macular degeneration Recall-at-100: 16.67%
2018-06-20 19:28:04,966:INFO: Experiment Progress: 56.0% -- 292/519
2018-06-20 19:28:05,540:INFO: Hyperplasia Recall-at-100: 6.67%
2018-06-20 19:28:05,541:INFO: Experiment Progress: 56.0% -- 293/519
2018-06-20 19:28:06,306:INFO: Pulmonary function (finding) Recall-at-100: 0.00%
2018-06-20 19:28:06,306:INFO: Experiment Progress: 56.0% -- 294/519
2018-06-20 19:28:06,776:INFO: Spina Bifida Recall-at-100: 20.00%
2018-06-20 19:28:06,776:INFO: Experiment Progress: 56.0% -- 295/519
2018-06-20 19:28:07,381:INFO: Hypertrophic Cardiomyopathy Recall-at-100: 13.33%
2018-06-20 19:28:07,381:INFO: Experiment Progress: 57.0% -- 296/519
2018-06-20 19:28:07,940:INFO: Bardet-Biedl Syndrome Recall-at-100: 71.67%
2018-06-20 19:28:07,941:INFO: Experiment Progress: 57.0% -- 297/519
2018-06-20 19:28:08,645:INFO: Keloid Recall-at-100: 15.83%
2018-06-20 19:28:08,645:INFO: Experiment Progress: 57.0% -- 298/519
2018-06-20 19:28:11,183:INFO: melanoma Recall-at-100: 3.13%
2018-06-20 19:28:11,183:INFO: Experiment Progress: 57.0% -- 299/519
2018-06-20 19:28:11,789:INFO: LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 Recall-at-100: 15.00%
2018-06-20 19:28:11,789:INFO: Experiment Progress: 57.0% -- 300/519
2018-06-20 19:28:12,648:INFO: Pneumonia Recall-at-100: 41.50%
2018-06-20 19:28:12,648:INFO: Experiment Progress: 57.0% -- 301/519
2018-06-20 19:28:14,205:INFO: Disease Progression Recall-at-100: 5.71%
2018-06-20 19:28:14,205:INFO: Experiment Progress: 58.0% -- 302/519
2018-06-20 19:28:14,710:INFO: Nephroblastoma Recall-at-100: 5.00%
2018-06-20 19:28:14,710:INFO: Experiment Progress: 58.0% -- 303/519
2018-06-20 19:28:15,125:INFO: Severe Combined Immunodeficiency Recall-at-100: 50.00%
2018-06-20 19:28:15,125:INFO: Experiment Progress: 58.0% -- 304/519
2018-06-20 19:28:15,564:INFO: Malignant neoplasm of ovary Recall-at-100: 10.00%
2018-06-20 19:28:15,565:INFO: Experiment Progress: 58.0% -- 305/519
2018-06-20 19:28:16,047:INFO: Pheochromocytoma Recall-at-100: 15.00%
2018-06-20 19:28:16,047:INFO: Experiment Progress: 58.0% -- 306/519
2018-06-20 19:28:16,571:INFO: Testicular Germ Cell Tumor Recall-at-100: 0.00%
2018-06-20 19:28:16,571:INFO: Experiment Progress: 59.0% -- 307/519
2018-06-20 19:28:17,012:INFO: Hypogonadism Recall-at-100: 90.00%
2018-06-20 19:28:17,012:INFO: Experiment Progress: 59.0% -- 308/519
2018-06-20 19:28:17,570:INFO: Movement Disorders Recall-at-100: 23.33%
2018-06-20 19:28:17,570:INFO: Experiment Progress: 59.0% -- 309/519
2018-06-20 19:28:18,037:INFO: Sarcoma Recall-at-100: 15.00%
2018-06-20 19:28:18,037:INFO: Experiment Progress: 59.0% -- 310/519
2018-06-20 19:28:18,487:INFO: Lymphatic Metastasis Recall-at-100: 0.00%
2018-06-20 19:28:18,487:INFO: Experiment Progress: 59.0% -- 311/519
2018-06-20 19:28:18,910:INFO: Hypoglycemia Recall-at-100: 10.00%
2018-06-20 19:28:18,910:INFO: Experiment Progress: 60.0% -- 312/519
2018-06-20 19:28:19,332:INFO: Anemia, Sickle Cell Recall-at-100: 0.00%
2018-06-20 19:28:19,332:INFO: Experiment Progress: 60.0% -- 313/519
2018-06-20 19:28:19,766:INFO: Muscular Dystrophy, Facioscapulohumeral Recall-at-100: 30.00%
2018-06-20 19:28:19,767:INFO: Experiment Progress: 60.0% -- 314/519
2018-06-20 19:28:20,394:INFO: Colorectal Cancer Recall-at-100: 6.67%
2018-06-20 19:28:20,395:INFO: Experiment Progress: 60.0% -- 315/519
2018-06-20 19:28:21,265:INFO: Atherosclerosis Recall-at-100: 8.67%
2018-06-20 19:28:21,265:INFO: Experiment Progress: 60.0% -- 316/519
2018-06-20 19:28:22,744:INFO: Asthma Recall-at-100: 2.00%
2018-06-20 19:28:22,744:INFO: Experiment Progress: 61.0% -- 317/519
2018-06-20 19:28:23,297:INFO: Cardiomyopathy, Hypertrophic, Familial Recall-at-100: 43.33%
2018-06-20 19:28:23,298:INFO: Experiment Progress: 61.0% -- 318/519
2018-06-20 19:28:24,058:INFO: Skin Neoplasms Recall-at-100: 16.50%
2018-06-20 19:28:24,058:INFO: Experiment Progress: 61.0% -- 319/519
2018-06-20 19:28:25,332:INFO: Seizures Recall-at-100: 1.00%
2018-06-20 19:28:25,332:INFO: Experiment Progress: 61.0% -- 320/519
2018-06-20 19:28:27,178:INFO: Alzheimer's Disease Recall-at-100: 6.19%
2018-06-20 19:28:27,178:INFO: Experiment Progress: 61.0% -- 321/519
2018-06-20 19:28:27,747:INFO: Menopause present (finding) Recall-at-100: 0.00%
2018-06-20 19:28:27,747:INFO: Experiment Progress: 62.0% -- 322/519
2018-06-20 19:28:28,903:INFO: Neoplastic Syndromes, Hereditary Recall-at-100: 28.50%
2018-06-20 19:28:28,903:INFO: Experiment Progress: 62.0% -- 323/519
2018-06-20 19:28:29,367:INFO: Gastrointestinal Diseases Recall-at-100: 20.00%
2018-06-20 19:28:29,368:INFO: Experiment Progress: 62.0% -- 324/519
2018-06-20 19:28:29,924:INFO: Cytochrome-c Oxidase Deficiency Recall-at-100: 35.00%
2018-06-20 19:28:29,924:INFO: Experiment Progress: 62.0% -- 325/519
2018-06-20 19:28:30,545:INFO: Retinal Degeneration Recall-at-100: 30.00%
2018-06-20 19:28:30,545:INFO: Experiment Progress: 62.0% -- 326/519
2018-06-20 19:28:31,148:INFO: Retinal Diseases Recall-at-100: 3.33%
2018-06-20 19:28:31,148:INFO: Experiment Progress: 63.0% -- 327/519
2018-06-20 19:28:31,603:INFO: Methylmalonic acidemia Recall-at-100: 40.00%
2018-06-20 19:28:31,603:INFO: Experiment Progress: 63.0% -- 328/519
2018-06-20 19:28:32,640:INFO: Contact Dermatitis Recall-at-100: 7.14%
2018-06-20 19:28:32,640:INFO: Experiment Progress: 63.0% -- 329/519
2018-06-20 19:28:33,376:INFO: Dermatitis, Atopic Recall-at-100: 25.00%
2018-06-20 19:28:33,376:INFO: Experiment Progress: 63.0% -- 330/519
2018-06-20 19:28:34,242:INFO: Coronary heart disease Recall-at-100: 8.67%
2018-06-20 19:28:34,242:INFO: Experiment Progress: 63.0% -- 331/519
2018-06-20 19:28:35,156:INFO: Osteoporosis Recall-at-100: 10.71%
2018-06-20 19:28:35,156:INFO: Experiment Progress: 63.0% -- 332/519
2018-06-20 19:28:36,065:INFO: Cardiomegaly Recall-at-100: 16.67%
2018-06-20 19:28:36,066:INFO: Experiment Progress: 64.0% -- 333/519
2018-06-20 19:28:37,154:INFO: Heart failure Recall-at-100: 7.50%
2018-06-20 19:28:37,154:INFO: Experiment Progress: 64.0% -- 334/519
2018-06-20 19:28:37,615:INFO: Hereditary Breast and Ovarian Cancer Syndrome Recall-at-100: 95.00%
2018-06-20 19:28:37,615:INFO: Experiment Progress: 64.0% -- 335/519
2018-06-20 19:28:38,290:INFO: Major Depressive Disorder Recall-at-100: 3.33%
2018-06-20 19:28:38,290:INFO: Experiment Progress: 64.0% -- 336/519
2018-06-20 19:28:39,354:INFO: Dermatologic disorders Recall-at-100: 0.00%
2018-06-20 19:28:39,354:INFO: Experiment Progress: 64.0% -- 337/519
2018-06-20 19:28:40,989:INFO: Inflammation Recall-at-100: 9.27%
2018-06-20 19:28:40,989:INFO: Experiment Progress: 65.0% -- 338/519
2018-06-20 19:28:41,436:INFO: Diabetic Neuropathies Recall-at-100: 25.00%
2018-06-20 19:28:41,436:INFO: Experiment Progress: 65.0% -- 339/519
2018-06-20 19:28:42,215:INFO: Male infertility Recall-at-100: 10.00%
2018-06-20 19:28:42,215:INFO: Experiment Progress: 65.0% -- 340/519
2018-06-20 19:28:42,787:INFO: Vascular Diseases Recall-at-100: 0.00%
2018-06-20 19:28:42,787:INFO: Experiment Progress: 65.0% -- 341/519
2018-06-20 19:28:44,114:INFO: Female infertility Recall-at-100: 31.67%
2018-06-20 19:28:44,114:INFO: Experiment Progress: 65.0% -- 342/519
2018-06-20 19:28:44,753:INFO: leukemia Recall-at-100: 22.50%
2018-06-20 19:28:44,753:INFO: Experiment Progress: 66.0% -- 343/519
2018-06-20 19:28:45,875:INFO: Ulcerative Colitis Recall-at-100: 6.25%
2018-06-20 19:28:45,875:INFO: Experiment Progress: 66.0% -- 344/519
2018-06-20 19:28:46,707:INFO: Influenza Recall-at-100: 22.00%
2018-06-20 19:28:46,707:INFO: Experiment Progress: 66.0% -- 345/519
2018-06-20 19:28:47,084:INFO: Nephritis, Interstitial Recall-at-100: 60.00%
2018-06-20 19:28:47,085:INFO: Experiment Progress: 66.0% -- 346/519
2018-06-20 19:28:47,526:INFO: Sjogren's Syndrome Recall-at-100: 10.00%
2018-06-20 19:28:47,526:INFO: Experiment Progress: 66.0% -- 347/519
2018-06-20 19:28:47,936:INFO: Infant length Recall-at-100: 0.00%
2018-06-20 19:28:47,937:INFO: Experiment Progress: 67.0% -- 348/519
2018-06-20 19:28:48,831:INFO: Child Development Disorders, Pervasive Recall-at-100: 13.67%
2018-06-20 19:28:48,831:INFO: Experiment Progress: 67.0% -- 349/519
2018-06-20 19:28:49,914:INFO: Substance Withdrawal Syndrome Recall-at-100: 23.00%
2018-06-20 19:28:49,915:INFO: Experiment Progress: 67.0% -- 350/519
2018-06-20 19:28:50,447:INFO: Malformations of Cortical Development Recall-at-100: 0.00%
2018-06-20 19:28:50,447:INFO: Experiment Progress: 67.0% -- 351/519
2018-06-20 19:28:51,585:INFO: Amyotrophic Lateral Sclerosis Recall-at-100: 8.10%
2018-06-20 19:28:51,585:INFO: Experiment Progress: 67.0% -- 352/519
2018-06-20 19:28:52,191:INFO: Developmental Disabilities Recall-at-100: 5.00%
2018-06-20 19:28:52,191:INFO: Experiment Progress: 68.0% -- 353/519
2018-06-20 19:28:52,702:INFO: Febrile Convulsions Recall-at-100: 0.00%
2018-06-20 19:28:52,702:INFO: Experiment Progress: 68.0% -- 354/519
2018-06-20 19:28:53,513:INFO: Cholestasis Recall-at-100: 10.00%
2018-06-20 19:28:53,513:INFO: Experiment Progress: 68.0% -- 355/519
2018-06-20 19:28:54,161:INFO: Pulmonary Hypertension Recall-at-100: 10.00%
2018-06-20 19:28:54,161:INFO: Experiment Progress: 68.0% -- 356/519
2018-06-20 19:28:54,766:INFO: Papillary thyroid carcinoma Recall-at-100: 13.33%
2018-06-20 19:28:54,766:INFO: Experiment Progress: 68.0% -- 357/519
2018-06-20 19:28:55,620:INFO: Salivary Gland Neoplasms Recall-at-100: 0.00%
2018-06-20 19:28:55,620:INFO: Experiment Progress: 68.0% -- 358/519
2018-06-20 19:28:56,381:INFO: Non-alcoholic Fatty Liver Disease Recall-at-100: 0.00%
2018-06-20 19:28:56,382:INFO: Experiment Progress: 69.0% -- 359/519
2018-06-20 19:28:56,804:INFO: Hay fever Recall-at-100: 0.00%
2018-06-20 19:28:56,804:INFO: Experiment Progress: 69.0% -- 360/519
2018-06-20 19:28:57,264:INFO: Hypercholesterolemia, Familial Recall-at-100: 60.00%
2018-06-20 19:28:57,265:INFO: Experiment Progress: 69.0% -- 361/519
2018-06-20 19:28:58,610:INFO: Down Syndrome Recall-at-100: 3.22%
2018-06-20 19:28:58,611:INFO: Experiment Progress: 69.0% -- 362/519
2018-06-20 19:28:59,025:INFO: Arrhythmogenic Right Ventricular Dysplasia Recall-at-100: 40.00%
2018-06-20 19:28:59,025:INFO: Experiment Progress: 69.0% -- 363/519
2018-06-20 19:28:59,451:INFO: Semilobar Holoprosencephaly Recall-at-100: 40.00%
2018-06-20 19:28:59,451:INFO: Experiment Progress: 70.0% -- 364/519
2018-06-20 19:28:59,945:INFO: Hypertriglyceridemia Recall-at-100: 20.00%
2018-06-20 19:28:59,946:INFO: Experiment Progress: 70.0% -- 365/519
2018-06-20 19:29:00,359:INFO: Sensorineural Hearing Loss (disorder) Recall-at-100: 22.22%
2018-06-20 19:29:00,360:INFO: Experiment Progress: 70.0% -- 366/519
2018-06-20 19:29:01,138:INFO: Metabolic Syndrome X Recall-at-100: 10.00%
2018-06-20 19:29:01,139:INFO: Experiment Progress: 70.0% -- 367/519
2018-06-20 19:29:01,626:INFO: Malignant neoplasm of lung Recall-at-100: 0.00%
2018-06-20 19:29:01,626:INFO: Experiment Progress: 70.0% -- 368/519
2018-06-20 19:29:03,219:INFO: Leukemia, Myelocytic, Acute Recall-at-100: 4.39%
2018-06-20 19:29:03,219:INFO: Experiment Progress: 71.0% -- 369/519
2018-06-20 19:29:04,275:INFO: Malignant neoplasm of prostate Recall-at-100: 4.76%
2018-06-20 19:29:04,276:INFO: Experiment Progress: 71.0% -- 370/519
2018-06-20 19:29:04,745:INFO: Renal Insufficiency Recall-at-100: 40.00%
2018-06-20 19:29:04,746:INFO: Experiment Progress: 71.0% -- 371/519
2018-06-20 19:29:05,100:INFO: Jeune thoracic dystrophy Recall-at-100: 66.67%
2018-06-20 19:29:05,100:INFO: Experiment Progress: 71.0% -- 372/519
2018-06-20 19:29:06,809:INFO: Renal Cell Carcinoma Recall-at-100: 6.60%
2018-06-20 19:29:06,809:INFO: Experiment Progress: 71.0% -- 373/519
2018-06-20 19:29:08,084:INFO: Squamous cell carcinoma Recall-at-100: 17.22%
2018-06-20 19:29:08,084:INFO: Experiment Progress: 72.0% -- 374/519
2018-06-20 19:29:09,655:INFO: Non-Small Cell Lung Carcinoma Recall-at-100: 7.12%
2018-06-20 19:29:09,656:INFO: Experiment Progress: 72.0% -- 375/519
2018-06-20 19:29:10,209:INFO: Manganese Poisoning Recall-at-100: 20.00%
2018-06-20 19:29:10,210:INFO: Experiment Progress: 72.0% -- 376/519
2018-06-20 19:29:10,746:INFO: Ventricular Dysfunction, Left Recall-at-100: 0.00%
2018-06-20 19:29:10,746:INFO: Experiment Progress: 72.0% -- 377/519
2018-06-20 19:29:11,416:INFO: Carcinoma, Transitional Cell Recall-at-100: 18.33%
2018-06-20 19:29:11,417:INFO: Experiment Progress: 72.0% -- 378/519
2018-06-20 19:29:11,839:INFO: Mucocutaneous Lymph Node Syndrome Recall-at-100: 0.00%
2018-06-20 19:29:11,839:INFO: Experiment Progress: 73.0% -- 379/519
2018-06-20 19:29:12,308:INFO: Tobacco Use Disorder Recall-at-100: 20.00%
2018-06-20 19:29:12,308:INFO: Experiment Progress: 73.0% -- 380/519
2018-06-20 19:29:13,077:INFO: Proteinuria Recall-at-100: 13.33%
2018-06-20 19:29:13,077:INFO: Experiment Progress: 73.0% -- 381/519
2018-06-20 19:29:13,798:INFO: Diabetic Nephropathy Recall-at-100: 2.50%
2018-06-20 19:29:13,799:INFO: Experiment Progress: 73.0% -- 382/519
2018-06-20 19:29:14,221:INFO: Williams Syndrome Recall-at-100: 20.00%
2018-06-20 19:29:14,221:INFO: Experiment Progress: 73.0% -- 383/519
2018-06-20 19:29:14,677:INFO: Oral Submucous Fibrosis Recall-at-100: 55.00%
2018-06-20 19:29:14,678:INFO: Experiment Progress: 73.0% -- 384/519
2018-06-20 19:29:15,304:INFO: Adenoma Recall-at-100: 6.67%
2018-06-20 19:29:15,304:INFO: Experiment Progress: 74.0% -- 385/519
2018-06-20 19:29:15,833:INFO: Neutropenia Recall-at-100: 10.00%
2018-06-20 19:29:15,834:INFO: Experiment Progress: 74.0% -- 386/519
2018-06-20 19:29:16,305:INFO: Poor school performance Recall-at-100: 0.00%
2018-06-20 19:29:16,305:INFO: Experiment Progress: 74.0% -- 387/519
2018-06-20 19:29:16,783:INFO: Pneumoconiosis Recall-at-100: 0.00%
2018-06-20 19:29:16,783:INFO: Experiment Progress: 74.0% -- 388/519
2018-06-20 19:29:17,643:INFO: Cardiovascular Diseases Recall-at-100: 20.00%
2018-06-20 19:29:17,643:INFO: Experiment Progress: 74.0% -- 389/519
2018-06-20 19:29:18,134:INFO: Fibrinogen Adverse Event Recall-at-100: 10.00%
2018-06-20 19:29:18,134:INFO: Experiment Progress: 75.0% -- 390/519
2018-06-20 19:29:20,003:INFO: Diabetes Mellitus, Non-Insulin-Dependent Recall-at-100: 6.46%
2018-06-20 19:29:20,004:INFO: Experiment Progress: 75.0% -- 391/519
2018-06-20 19:29:20,553:INFO: Thrombocytopenia Recall-at-100: 15.00%
2018-06-20 19:29:20,553:INFO: Experiment Progress: 75.0% -- 392/519
2018-06-20 19:29:21,141:INFO: Sezary Syndrome Recall-at-100: 20.00%
2018-06-20 19:29:21,142:INFO: Experiment Progress: 75.0% -- 393/519
2018-06-20 19:29:21,589:INFO: Nuclear non-senile cataract Recall-at-100: 50.00%
2018-06-20 19:29:21,589:INFO: Experiment Progress: 75.0% -- 394/519
2018-06-20 19:29:22,078:INFO: Diabetic Retinopathy Recall-at-100: 0.00%
2018-06-20 19:29:22,078:INFO: Experiment Progress: 76.0% -- 395/519
2018-06-20 19:29:22,781:INFO: hearing impairment Recall-at-100: 0.00%
2018-06-20 19:29:22,781:INFO: Experiment Progress: 76.0% -- 396/519
2018-06-20 19:29:23,266:INFO: Psychotic Disorders Recall-at-100: 25.00%
2018-06-20 19:29:23,267:INFO: Experiment Progress: 76.0% -- 397/519
2018-06-20 19:29:23,925:INFO: Anxiety Disorders Recall-at-100: 11.67%
2018-06-20 19:29:23,925:INFO: Experiment Progress: 76.0% -- 398/519
2018-06-20 19:29:24,398:INFO: Finding of Mean Corpuscular Hemoglobin Recall-at-100: 15.00%
2018-06-20 19:29:24,398:INFO: Experiment Progress: 76.0% -- 399/519
2018-06-20 19:29:24,862:INFO: Motion Sickness Recall-at-100: 0.00%
2018-06-20 19:29:24,862:INFO: Experiment Progress: 77.0% -- 400/519
2018-06-20 19:29:25,407:INFO: Lymphoma, Non-Hodgkin Recall-at-100: 33.33%
2018-06-20 19:29:25,408:INFO: Experiment Progress: 77.0% -- 401/519
2018-06-20 19:29:25,948:INFO: Lymphoma, Follicular Recall-at-100: 10.00%
2018-06-20 19:29:25,948:INFO: Experiment Progress: 77.0% -- 402/519
2018-06-20 19:29:26,400:INFO: Thrombocythemia, Essential Recall-at-100: 40.00%
2018-06-20 19:29:26,400:INFO: Experiment Progress: 77.0% -- 403/519
2018-06-20 19:29:26,774:INFO: Arthritis Recall-at-100: 0.00%
2018-06-20 19:29:26,774:INFO: Experiment Progress: 77.0% -- 404/519
2018-06-20 19:29:27,617:INFO: Hypotension Recall-at-100: 22.67%
2018-06-20 19:29:27,617:INFO: Experiment Progress: 78.0% -- 405/519
2018-06-20 19:29:28,764:INFO: Reperfusion Injury Recall-at-100: 16.25%
2018-06-20 19:29:28,765:INFO: Experiment Progress: 78.0% -- 406/519
2018-06-20 19:29:29,237:INFO: Heat Stroke Recall-at-100: 70.00%
2018-06-20 19:29:29,237:INFO: Experiment Progress: 78.0% -- 407/519
2018-06-20 19:29:29,763:INFO: Hemangiosarcoma Recall-at-100: 55.00%
2018-06-20 19:29:29,763:INFO: Experiment Progress: 78.0% -- 408/519
2018-06-20 19:29:30,440:INFO: Drug Allergy Recall-at-100: 20.00%
2018-06-20 19:29:30,440:INFO: Experiment Progress: 78.0% -- 409/519
2018-06-20 19:29:30,891:INFO: SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR Recall-at-100: 40.00%
2018-06-20 19:29:30,892:INFO: Experiment Progress: 78.0% -- 410/519
2018-06-20 19:29:31,704:INFO: Medulloblastoma Recall-at-100: 9.50%
2018-06-20 19:29:31,705:INFO: Experiment Progress: 79.0% -- 411/519
2018-06-20 19:29:32,264:INFO: Cleft Lip Recall-at-100: 50.00%
2018-06-20 19:29:32,264:INFO: Experiment Progress: 79.0% -- 412/519
2018-06-20 19:29:32,979:INFO: Cleft Palate Recall-at-100: 27.50%
2018-06-20 19:29:32,979:INFO: Experiment Progress: 79.0% -- 413/519
2018-06-20 19:29:34,285:INFO: Muscle Weakness Recall-at-100: 4.33%
2018-06-20 19:29:34,285:INFO: Experiment Progress: 79.0% -- 414/519
2018-06-20 19:29:34,723:INFO: Mental disorders Recall-at-100: 0.00%
2018-06-20 19:29:34,724:INFO: Experiment Progress: 79.0% -- 415/519
2018-06-20 19:29:35,291:INFO: Astrocytoma Recall-at-100: 45.00%
2018-06-20 19:29:35,291:INFO: Experiment Progress: 80.0% -- 416/519
2018-06-20 19:29:35,746:INFO: Anemia, Diamond-Blackfan Recall-at-100: 85.00%
2018-06-20 19:29:35,746:INFO: Experiment Progress: 80.0% -- 417/519
2018-06-20 19:29:36,171:INFO: Asthma, Aspirin-Induced Recall-at-100: 35.00%
2018-06-20 19:29:36,172:INFO: Experiment Progress: 80.0% -- 418/519
2018-06-20 19:29:36,708:INFO: Leber Congenital Amaurosis Recall-at-100: 10.00%
2018-06-20 19:29:36,708:INFO: Experiment Progress: 80.0% -- 419/519
2018-06-20 19:29:37,097:INFO: Cachexia Recall-at-100: 20.00%
2018-06-20 19:29:37,097:INFO: Experiment Progress: 80.0% -- 420/519
2018-06-20 19:29:37,526:INFO: Respiratory Insufficiency Recall-at-100: 0.00%
2018-06-20 19:29:37,526:INFO: Experiment Progress: 81.0% -- 421/519
2018-06-20 19:29:38,020:INFO: Respiratory Hypersensitivity Recall-at-100: 20.00%
2018-06-20 19:29:38,021:INFO: Experiment Progress: 81.0% -- 422/519
2018-06-20 19:29:38,571:INFO: Nasopharyngeal carcinoma Recall-at-100: 20.00%
2018-06-20 19:29:38,571:INFO: Experiment Progress: 81.0% -- 423/519
2018-06-20 19:29:39,576:INFO: Hyperalgesia Recall-at-100: 15.71%
2018-06-20 19:29:39,576:INFO: Experiment Progress: 81.0% -- 424/519
2018-06-20 19:29:40,018:INFO: Meningioma Recall-at-100: 35.00%
2018-06-20 19:29:40,018:INFO: Experiment Progress: 81.0% -- 425/519
2018-06-20 19:29:40,481:INFO: Sudden Cardiac Arrest Recall-at-100: 5.00%
2018-06-20 19:29:40,481:INFO: Experiment Progress: 82.0% -- 426/519
2018-06-20 19:29:42,183:INFO: Intellectual Disability Recall-at-100: 0.77%
2018-06-20 19:29:42,184:INFO: Experiment Progress: 82.0% -- 427/519
2018-06-20 19:29:42,622:INFO: Graves Disease Recall-at-100: 10.00%
2018-06-20 19:29:42,622:INFO: Experiment Progress: 82.0% -- 428/519
2018-06-20 19:29:43,231:INFO: Neurotoxicity Syndromes Recall-at-100: 0.00%
2018-06-20 19:29:43,231:INFO: Experiment Progress: 82.0% -- 429/519
2018-06-20 19:29:43,621:INFO: Cardiomyopathy, Familial Hypertrophic, 1 (disorder) Recall-at-100: 70.00%
2018-06-20 19:29:43,621:INFO: Experiment Progress: 82.0% -- 430/519
2018-06-20 19:29:44,238:INFO: Atrial Fibrillation Recall-at-100: 8.33%
2018-06-20 19:29:44,238:INFO: Experiment Progress: 83.0% -- 431/519
2018-06-20 19:29:44,771:INFO: Hepatitis, Chronic Recall-at-100: 28.33%
2018-06-20 19:29:44,771:INFO: Experiment Progress: 83.0% -- 432/519
2018-06-20 19:29:45,321:INFO: Behcet Syndrome Recall-at-100: 16.67%
2018-06-20 19:29:45,321:INFO: Experiment Progress: 83.0% -- 433/519
2018-06-20 19:29:46,360:INFO: Diabetes Mellitus, Insulin-Dependent Recall-at-100: 4.29%
2018-06-20 19:29:46,360:INFO: Experiment Progress: 83.0% -- 434/519
2018-06-20 19:29:47,760:INFO: Diabetes Mellitus, Experimental Recall-at-100: 10.45%
2018-06-20 19:29:47,761:INFO: Experiment Progress: 83.0% -- 435/519
2018-06-20 19:29:48,300:INFO: Parkinsonian Disorders Recall-at-100: 23.33%
2018-06-20 19:29:48,301:INFO: Experiment Progress: 84.0% -- 436/519
2018-06-20 19:29:49,141:INFO: Necrosis Recall-at-100: 12.00%
2018-06-20 19:29:49,141:INFO: Experiment Progress: 84.0% -- 437/519
2018-06-20 19:29:49,591:INFO: Gestational Diabetes Recall-at-100: 0.00%
2018-06-20 19:29:49,591:INFO: Experiment Progress: 84.0% -- 438/519
2018-06-20 19:29:50,072:INFO: Idiopathic Membranous Glomerulonephritis Recall-at-100: 0.00%
2018-06-20 19:29:50,072:INFO: Experiment Progress: 84.0% -- 439/519
2018-06-20 19:29:51,018:INFO: Hypersensitivity Recall-at-100: 28.81%
2018-06-20 19:29:51,019:INFO: Experiment Progress: 84.0% -- 440/519
2018-06-20 19:29:51,621:INFO: Myopia Recall-at-100: 3.33%
2018-06-20 19:29:51,621:INFO: Experiment Progress: 84.0% -- 441/519
2018-06-20 19:29:52,101:INFO: Hyperemia Recall-at-100: 20.00%
2018-06-20 19:29:52,101:INFO: Experiment Progress: 85.0% -- 442/519
2018-06-20 19:29:52,510:INFO: Tooth Abnormalities Recall-at-100: 0.00%
2018-06-20 19:29:52,510:INFO: Experiment Progress: 85.0% -- 443/519
2018-06-20 19:29:53,045:INFO: Hyperglycemia Recall-at-100: 10.00%
2018-06-20 19:29:53,045:INFO: Experiment Progress: 85.0% -- 444/519
2018-06-20 19:29:53,521:INFO: Noonan Syndrome Recall-at-100: 65.00%
2018-06-20 19:29:53,522:INFO: Experiment Progress: 85.0% -- 445/519
2018-06-20 19:29:53,984:INFO: Hyperinsulinism Recall-at-100: 30.00%
2018-06-20 19:29:53,984:INFO: Experiment Progress: 85.0% -- 446/519
2018-06-20 19:29:54,533:INFO: Edema Recall-at-100: 10.00%
2018-06-20 19:29:54,533:INFO: Experiment Progress: 86.0% -- 447/519
2018-06-20 19:29:54,992:INFO: Hodgkin Disease Recall-at-100: 5.00%
2018-06-20 19:29:54,992:INFO: Experiment Progress: 86.0% -- 448/519
2018-06-20 19:29:55,419:INFO: Metabolic Bone Disorder Recall-at-100: 20.00%
2018-06-20 19:29:55,419:INFO: Experiment Progress: 86.0% -- 449/519
2018-06-20 19:29:56,005:INFO: Bone Diseases, Developmental Recall-at-100: 0.00%
2018-06-20 19:29:56,005:INFO: Experiment Progress: 86.0% -- 450/519
2018-06-20 19:29:56,439:INFO: Tachycardia, Ventricular Recall-at-100: 0.00%
2018-06-20 19:29:56,439:INFO: Experiment Progress: 86.0% -- 451/519
2018-06-20 19:29:56,930:INFO: Dystonia Recall-at-100: 0.00%
2018-06-20 19:29:56,931:INFO: Experiment Progress: 87.0% -- 452/519
2018-06-20 19:29:57,486:INFO: Squamous cell carcinoma of the head and neck Recall-at-100: 10.00%
2018-06-20 19:29:57,487:INFO: Experiment Progress: 87.0% -- 453/519
2018-06-20 19:29:57,923:INFO: Pulmonary Embolism Recall-at-100: 35.00%
2018-06-20 19:29:57,923:INFO: Experiment Progress: 87.0% -- 454/519
2018-06-20 19:29:58,730:INFO: Pulmonary Fibrosis Recall-at-100: 35.00%
2018-06-20 19:29:58,730:INFO: Experiment Progress: 87.0% -- 455/519
2018-06-20 19:29:59,213:INFO: West Syndrome Recall-at-100: 10.00%
2018-06-20 19:29:59,213:INFO: Experiment Progress: 87.0% -- 456/519
2018-06-20 19:29:59,787:INFO: Cerebral Hemorrhage Recall-at-100: 46.67%
2018-06-20 19:29:59,788:INFO: Experiment Progress: 88.0% -- 457/519
2018-06-20 19:30:00,241:INFO: Romano-Ward Syndrome Recall-at-100: 55.00%
2018-06-20 19:30:00,241:INFO: Experiment Progress: 88.0% -- 458/519
2018-06-20 19:30:00,966:INFO: Mouth Neoplasms Recall-at-100: 17.50%
2018-06-20 19:30:00,966:INFO: Experiment Progress: 88.0% -- 459/519
2018-06-20 19:30:01,839:INFO: Liver Cirrhosis Recall-at-100: 23.33%
2018-06-20 19:30:01,839:INFO: Experiment Progress: 88.0% -- 460/519
2018-06-20 19:30:02,383:INFO: Neoplasm Recurrence, Local Recall-at-100: 13.33%
2018-06-20 19:30:02,383:INFO: Experiment Progress: 88.0% -- 461/519
2018-06-20 19:30:05,297:INFO: Obesity Recall-at-100: 3.12%
2018-06-20 19:30:05,297:INFO: Experiment Progress: 89.0% -- 462/519
2018-06-20 19:30:05,932:INFO: Biliary cirrhosis Recall-at-100: 15.00%
2018-06-20 19:30:05,933:INFO: Experiment Progress: 89.0% -- 463/519
2018-06-20 19:30:06,717:INFO: Precursor Cell Lymphoblastic Leukemia Lymphoma Recall-at-100: 12.00%
2018-06-20 19:30:06,717:INFO: Experiment Progress: 89.0% -- 464/519
2018-06-20 19:30:07,948:INFO: Cardiomyopathies Recall-at-100: 10.00%
2018-06-20 19:30:07,948:INFO: Experiment Progress: 89.0% -- 465/519
2018-06-20 19:30:08,363:INFO: Peroxisome biogenesis disorders Recall-at-100: 100.00%
2018-06-20 19:30:08,363:INFO: Experiment Progress: 89.0% -- 466/519
2018-06-20 19:30:08,840:INFO: Dyskeratosis Congenita Recall-at-100: 55.00%
2018-06-20 19:30:08,840:INFO: Experiment Progress: 89.0% -- 467/519
2018-06-20 19:30:09,337:INFO: Uremia Recall-at-100: 25.00%
2018-06-20 19:30:09,337:INFO: Experiment Progress: 90.0% -- 468/519
2018-06-20 19:30:10,024:INFO: Depressive disorder Recall-at-100: 12.50%
2018-06-20 19:30:10,024:INFO: Experiment Progress: 90.0% -- 469/519
2018-06-20 19:30:10,772:INFO: Thrombosis Recall-at-100: 50.00%
2018-06-20 19:30:10,772:INFO: Experiment Progress: 90.0% -- 470/519
2018-06-20 19:30:11,610:INFO: nervous system disorder Recall-at-100: 5.67%
2018-06-20 19:30:11,610:INFO: Experiment Progress: 90.0% -- 471/519
2018-06-20 19:30:12,111:INFO: Lymphoma Recall-at-100: 0.00%
2018-06-20 19:30:12,111:INFO: Experiment Progress: 90.0% -- 472/519
2018-06-20 19:30:17,432:INFO: IGA Glomerulonephritis Recall-at-100: 1.86%
2018-06-20 19:30:17,432:INFO: Experiment Progress: 91.0% -- 473/519
2018-06-20 19:30:18,031:INFO: Kidney Neoplasm Recall-at-100: 20.00%
2018-06-20 19:30:18,031:INFO: Experiment Progress: 91.0% -- 474/519
2018-06-20 19:30:18,469:INFO: Hypothermia, natural Recall-at-100: 25.00%
2018-06-20 19:30:18,469:INFO: Experiment Progress: 91.0% -- 475/519
2018-06-20 19:30:19,006:INFO: Focal glomerulosclerosis Recall-at-100: 21.67%
2018-06-20 19:30:19,006:INFO: Experiment Progress: 91.0% -- 476/519
2018-06-20 19:30:19,458:INFO: Hepatitis B, Chronic Recall-at-100: 0.00%
2018-06-20 19:30:19,459:INFO: Experiment Progress: 91.0% -- 477/519
2018-06-20 19:30:19,949:INFO: Drug Eruptions Recall-at-100: 0.00%
2018-06-20 19:30:19,949:INFO: Experiment Progress: 92.0% -- 478/519
2018-06-20 19:30:20,394:INFO: Malignant neoplasm of pancreas Recall-at-100: 0.00%
2018-06-20 19:30:20,394:INFO: Experiment Progress: 92.0% -- 479/519
2018-06-20 19:30:23,550:INFO: Stomach Neoplasms Recall-at-100: 5.30%
2018-06-20 19:30:23,551:INFO: Experiment Progress: 92.0% -- 480/519
2018-06-20 19:30:24,257:INFO: Osteosarcoma Recall-at-100: 14.17%
2018-06-20 19:30:24,258:INFO: Experiment Progress: 92.0% -- 481/519
2018-06-20 19:30:24,893:INFO: Vitiligo Recall-at-100: 6.67%
2018-06-20 19:30:24,893:INFO: Experiment Progress: 92.0% -- 482/519
2018-06-20 19:30:25,367:INFO: Gastric ulcer Recall-at-100: 5.00%
2018-06-20 19:30:25,367:INFO: Experiment Progress: 93.0% -- 483/519
2018-06-20 19:30:26,366:INFO: Malignant neoplasm of breast Recall-at-100: 11.43%
2018-06-20 19:30:26,366:INFO: Experiment Progress: 93.0% -- 484/519
2018-06-20 19:30:27,915:INFO: Drug-Induced Liver Injury Recall-at-100: 9.24%
2018-06-20 19:30:27,915:INFO: Experiment Progress: 93.0% -- 485/519
2018-06-20 19:30:28,472:INFO: Colitis Recall-at-100: 11.67%
2018-06-20 19:30:28,473:INFO: Experiment Progress: 93.0% -- 486/519
2018-06-20 19:30:29,003:INFO: Lymphoma, T-Cell, Cutaneous Recall-at-100: 5.00%
2018-06-20 19:30:29,003:INFO: Experiment Progress: 93.0% -- 487/519
2018-06-20 19:30:29,426:INFO: T-Cell Lymphoma Recall-at-100: 40.00%
2018-06-20 19:30:29,426:INFO: Experiment Progress: 94.0% -- 488/519
2018-06-20 19:30:30,040:INFO: Hyperactive behavior Recall-at-100: 20.00%
2018-06-20 19:30:30,041:INFO: Experiment Progress: 94.0% -- 489/519
2018-06-20 19:30:30,457:INFO: Skin Abnormalities Recall-at-100: 0.00%
2018-06-20 19:30:30,457:INFO: Experiment Progress: 94.0% -- 490/519
2018-06-20 19:30:30,968:INFO: Epithelial ovarian cancer Recall-at-100: 5.00%
2018-06-20 19:30:30,968:INFO: Experiment Progress: 94.0% -- 491/519
2018-06-20 19:30:31,428:INFO: Infantile Refsum Disease (disorder) Recall-at-100: 100.00%
2018-06-20 19:30:31,428:INFO: Experiment Progress: 94.0% -- 492/519
2018-06-20 19:30:31,876:INFO: Adrenoleukodystrophy, Neonatal Recall-at-100: 100.00%
2018-06-20 19:30:31,876:INFO: Experiment Progress: 94.0% -- 493/519
2018-06-20 19:30:32,284:INFO: Hirschsprung Disease Recall-at-100: 50.00%
2018-06-20 19:30:32,284:INFO: Experiment Progress: 95.0% -- 494/519
2018-06-20 19:30:32,783:INFO: Female Urogenital Diseases Recall-at-100: 20.00%
2018-06-20 19:30:32,784:INFO: Experiment Progress: 95.0% -- 495/519
2018-06-20 19:30:34,100:INFO: ovarian neoplasm Recall-at-100: 13.44%
2018-06-20 19:30:34,100:INFO: Experiment Progress: 95.0% -- 496/519
2018-06-20 19:30:34,542:INFO: Aortic Aneurysm, Abdominal Recall-at-100: 15.00%
2018-06-20 19:30:34,542:INFO: Experiment Progress: 95.0% -- 497/519
2018-06-20 19:30:35,028:INFO: Venous Thrombosis Recall-at-100: 75.00%
2018-06-20 19:30:35,028:INFO: Experiment Progress: 95.0% -- 498/519
2018-06-20 19:30:35,514:INFO: Amnesia Recall-at-100: 15.00%
2018-06-20 19:30:35,514:INFO: Experiment Progress: 96.0% -- 499/519
2018-06-20 19:30:36,923:INFO: Bladder Neoplasm Recall-at-100: 9.55%
2018-06-20 19:30:36,923:INFO: Experiment Progress: 96.0% -- 500/519
2018-06-20 19:30:37,401:INFO: Hemorrhage Recall-at-100: 15.00%
2018-06-20 19:30:37,401:INFO: Experiment Progress: 96.0% -- 501/519
2018-06-20 19:30:38,359:INFO: Status Epilepticus Recall-at-100: 23.10%
2018-06-20 19:30:38,359:INFO: Experiment Progress: 96.0% -- 502/519
2018-06-20 19:30:38,919:INFO: Chronic Kidney Diseases Recall-at-100: 0.00%
2018-06-20 19:30:38,919:INFO: Experiment Progress: 96.0% -- 503/519
2018-06-20 19:30:39,453:INFO: Myeloid Leukemia, Chronic Recall-at-100: 26.67%
2018-06-20 19:30:39,453:INFO: Experiment Progress: 97.0% -- 504/519
2018-06-20 19:30:39,954:INFO: Myeloid Leukemia Recall-at-100: 35.00%
2018-06-20 19:30:39,954:INFO: Experiment Progress: 97.0% -- 505/519
2018-06-20 19:30:40,650:INFO: Calcinosis Recall-at-100: 17.50%
2018-06-20 19:30:40,651:INFO: Experiment Progress: 97.0% -- 506/519
2018-06-20 19:30:41,093:INFO: Creutzfeldt-Jakob disease Recall-at-100: 0.00%
2018-06-20 19:30:41,093:INFO: Experiment Progress: 97.0% -- 507/519
2018-06-20 19:30:41,516:INFO: Left ventricular noncompaction Recall-at-100: 15.00%
2018-06-20 19:30:41,516:INFO: Experiment Progress: 97.0% -- 508/519
2018-06-20 19:30:42,848:INFO: Parkinson Disease Recall-at-100: 6.22%
2018-06-20 19:30:42,848:INFO: Experiment Progress: 98.0% -- 509/519
2018-06-20 19:30:43,663:INFO: Endometrial Neoplasms Recall-at-100: 12.00%
2018-06-20 19:30:43,663:INFO: Experiment Progress: 98.0% -- 510/519
2018-06-20 19:30:44,219:INFO: Sepsis Recall-at-100: 15.00%
2018-06-20 19:30:44,219:INFO: Experiment Progress: 98.0% -- 511/519
2018-06-20 19:30:46,101:INFO: Endometriosis Recall-at-100: 11.83%
2018-06-20 19:30:46,101:INFO: Experiment Progress: 98.0% -- 512/519
2018-06-20 19:30:47,110:INFO: Esophageal Neoplasms Recall-at-100: 10.48%
2018-06-20 19:30:47,110:INFO: Experiment Progress: 98.0% -- 513/519
2018-06-20 19:30:47,603:INFO: Eosinophilic esophagitis Recall-at-100: 0.00%
2018-06-20 19:30:47,603:INFO: Experiment Progress: 99.0% -- 514/519
2018-06-20 19:30:48,099:INFO: Malignant neoplasm of urinary bladder Recall-at-100: 15.00%
2018-06-20 19:30:48,099:INFO: Experiment Progress: 99.0% -- 515/519
2018-06-20 19:30:48,601:INFO: Lewy Body Disease Recall-at-100: 35.00%
2018-06-20 19:30:48,601:INFO: Experiment Progress: 99.0% -- 516/519
2018-06-20 19:30:49,088:INFO: PARKINSON DISEASE, LATE-ONSET Recall-at-100: 0.00%
2018-06-20 19:30:49,088:INFO: Experiment Progress: 99.0% -- 517/519
2018-06-20 19:30:50,239:INFO: Neoplastic Cell Transformation Recall-at-100: 15.69%
2018-06-20 19:30:50,239:INFO: Experiment Progress: 99.0% -- 518/519
2018-06-20 19:30:51,120:INFO: Arsenic Poisoning Recall-at-100: 1.67%
